<?xml version="1.0" encoding="UTF-8" standalone="yes"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><generator>NFE/5.0</generator><title>"생동시험" - Google 뉴스</title><link>https://news.google.com/search?pz=1&amp;cf=all&amp;hl=ko&amp;q=%EC%83%9D%EB%8F%99%EC%8B%9C%ED%97%98&amp;cf=all&amp;gl=KR&amp;ceid=KR:ko</link><language>ko</language><webMaster>news-webmaster@google.com</webMaster><copyright>Copyright © 2026 Google. All rights reserved. This XML feed is made available solely for the purpose of rendering Google News results within a personal feed reader for personal, non-commercial use. Any other use of the feed is expressly prohibited. By accessing this feed or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><lastBuildDate>Sun, 03 May 2026 02:08:02 GMT</lastBuildDate><image><title>Google 뉴스</title><url>https://lh3.googleusercontent.com/-DR60l-K8vnyi99NZovm9HlXyZwQ85GMDxiwJWzoasZYCUrPuUM_P_4Rb7ei03j-0nRs0c4F=w256</url><link>https://news.google.com/</link><height>256</height><width>256</width></image><description>Google 뉴스</description><item><title>식약처, 제조소 이전 시 의약품 동등성시험 부담 완화 - 메디팜스투데이</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTFBKaV9Vekk3RTRXajJaWHBQS0ZmWFFhV0dIMTVFbWstMDIwSTRvQnlGWnRsZGxodGxMVzU1bVB6eWE4QThZQlF0OUdweXFzcU9tWjMxYzRUTDlOVkdOMHlpb2Q2SDJ5X2lk?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTFBKaV9Vekk3RTRXajJaWHBQS0ZmWFFhV0dIMTVFbWstMDIwSTRvQnlGWnRsZGxodGxMVzU1bVB6eWE4QThZQlF0OUdweXFzcU9tWjMxYzRUTDlOVkdOMHlpb2Q2SDJ5X2lk</guid><pubDate>Wed, 29 Apr 2026 01:19:03 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTFBKaV9Vekk3RTRXajJaWHBQS0ZmWFFhV0dIMTVFbWstMDIwSTRvQnlGWnRsZGxodGxMVzU1bVB6eWE4QThZQlF0OUdweXFzcU9tWjMxYzRUTDlOVkdOMHlpb2Q2SDJ5X2lk?oc=5" target="_blank"&gt;식약처, 제조소 이전 시 의약품 동등성시험 부담 완화&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디팜스투데이&lt;/font&gt;</description><source url="https://www.apsk.co.kr">메디팜스투데이</source></item><item><title>식약처 "의약품동등성시험 제출자료 합리적 개선" - 뉴시스</title><link>https://news.google.com/rss/articles/CBMieEFVX3lxTE94UkpEamFWVkpjbWpOUWJhODZmSm8yV3ZTbGNrMmF0NEphWFNLY2VOWkRWZFR5REtWODlTOE1VZVduSnFmZzc4dUNmdXJrcXV1ck9nYlRMZ0tZdmZTX1gyWkVsN01naEJnUkhkMjJhSHFteldISUdjedIBeEFVX3lxTE94UkpEamFWVkpjbWpOUWJhODZmSm8yV3ZTbGNrMmF0NEphWFNLY2VOWkRWZFR5REtWODlTOE1VZVduSnFmZzc4dUNmdXJrcXV1ck9nYlRMZ0tZdmZTX1gyWkVsN01naEJnUkhkMjJhSHFteldISUdjeQ?oc=5</link><guid isPermaLink="false">CBMieEFVX3lxTE94UkpEamFWVkpjbWpOUWJhODZmSm8yV3ZTbGNrMmF0NEphWFNLY2VOWkRWZFR5REtWODlTOE1VZVduSnFmZzc4dUNmdXJrcXV1ck9nYlRMZ0tZdmZTX1gyWkVsN01naEJnUkhkMjJhSHFteldISUdjedIBeEFVX3lxTE94UkpEamFWVkpjbWpOUWJhODZmSm8yV3ZTbGNrMmF0NEphWFNLY2VOWkRWZFR5REtWODlTOE1VZVduSnFmZzc4dUNmdXJrcXV1ck9nYlRMZ0tZdmZTX1gyWkVsN01naEJnUkhkMjJhSHFteldISUdjeQ</guid><pubDate>Wed, 29 Apr 2026 00:36:16 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMieEFVX3lxTE94UkpEamFWVkpjbWpOUWJhODZmSm8yV3ZTbGNrMmF0NEphWFNLY2VOWkRWZFR5REtWODlTOE1VZVduSnFmZzc4dUNmdXJrcXV1ck9nYlRMZ0tZdmZTX1gyWkVsN01naEJnUkhkMjJhSHFteldISUdjedIBeEFVX3lxTE94UkpEamFWVkpjbWpOUWJhODZmSm8yV3ZTbGNrMmF0NEphWFNLY2VOWkRWZFR5REtWODlTOE1VZVduSnFmZzc4dUNmdXJrcXV1ck9nYlRMZ0tZdmZTX1gyWkVsN01naEJnUkhkMjJhSHFteldISUdjeQ?oc=5" target="_blank"&gt;식약처 "의약품동등성시험 제출자료 합리적 개선"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴시스&lt;/font&gt;</description><source url="https://mobile.newsis.com">뉴시스</source></item><item><title>제조소 변경, 생동시험 일률 요구 없앤다…동등성 기준 ‘차등화’ - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE4xNnRqbnVkS2hXdk12UjlMOThaTDJtUkNFNWwyM3djTlFfUmhvbnFhSmNIZDk5Z0x0ajMzcVJNb042TUVmRWhjSWNHaEtZQXJUWmZGbFY3NG1EOEJkSU1yNE5DV085Y1FNckFJWQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE4xNnRqbnVkS2hXdk12UjlMOThaTDJtUkNFNWwyM3djTlFfUmhvbnFhSmNIZDk5Z0x0ajMzcVJNb042TUVmRWhjSWNHaEtZQXJUWmZGbFY3NG1EOEJkSU1yNE5DV085Y1FNckFJWQ</guid><pubDate>Wed, 18 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE4xNnRqbnVkS2hXdk12UjlMOThaTDJtUkNFNWwyM3djTlFfUmhvbnFhSmNIZDk5Z0x0ajMzcVJNb042TUVmRWhjSWNHaEtZQXJUWmZGbFY3NG1EOEJkSU1yNE5DV085Y1FNckFJWQ?oc=5" target="_blank"&gt;제조소 변경, 생동시험 일률 요구 없앤다…동등성 기준 ‘차등화’&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>기등재 제네릭도 생동시험?…약가인하 속타는 제약사들 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiVkFVX3lxTE1vY1gwRDZRa050T1RneVdqakYyb1dTMWxrZUJ6YUJzWnFNQ1BFOUl2MXVTNEkxdjVhaERzWU96WUpZNUZGbFY4cG1xcnFSeWtxTEZmeWpR?oc=5</link><guid isPermaLink="false">CBMiVkFVX3lxTE1vY1gwRDZRa050T1RneVdqakYyb1dTMWxrZUJ6YUJzWnFNQ1BFOUl2MXVTNEkxdjVhaERzWU96WUpZNUZGbFY4cG1xcnFSeWtxTEZmeWpR</guid><pubDate>Tue, 31 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE1vY1gwRDZRa050T1RneVdqakYyb1dTMWxrZUJ6YUJzWnFNQ1BFOUl2MXVTNEkxdjVhaERzWU96WUpZNUZGbFY4cG1xcnFSeWtxTEZmeWpR?oc=5" target="_blank"&gt;기등재 제네릭도 생동시험?…약가인하 속타는 제약사들&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://www.dailypharm.com">데일리팜</source></item><item><title>제조소 이전에 생동시험 없다…식약처 20년 만 규제 대수술 - 약업신문</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTE4tc1dUSURRaV83elNBaTBPSFhCUGVDWXNJU0dCb1lXTEZ0eVdxYS1ucUtfZl9yS2dDMnE4bEhTWU5GSE5WalZwRS10MEt1am1FLVVJVXFwSGstSzUzZzktYktEWTVLZw?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTE4tc1dUSURRaV83elNBaTBPSFhCUGVDWXNJU0dCb1lXTEZ0eVdxYS1ucUtfZl9yS2dDMnE4bEhTWU5GSE5WalZwRS10MEt1am1FLVVJVXFwSGstSzUzZzktYktEWTVLZw</guid><pubDate>Thu, 27 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE4tc1dUSURRaV83elNBaTBPSFhCUGVDWXNJU0dCb1lXTEZ0eVdxYS1ucUtfZl9yS2dDMnE4bEhTWU5GSE5WalZwRS10MEt1am1FLVVJVXFwSGstSzUzZzktYktEWTVLZw?oc=5" target="_blank"&gt;제조소 이전에 생동시험 없다…식약처 20년 만 규제 대수술&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약업신문&lt;/font&gt;</description><source url="http://m.yakup.com">약업신문</source></item><item><title>대웅제약 성조숙증약 ‘루피어’, 시장 잔류 걸린 생동시험에 주목 - 메디소비자뉴스</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTFAxRHU5aFBscDR4ZDhLWF9NVks2WWIwcGN1eUJIeHFXLVp0WnhKVkVlX2JtaUxLZUpSNFhrcjJMbnFnUlJtT1l0b2lNdkdOWUhieENaUzNaLVlFaWw1a2VjcmVUdkpmeGhpWVB2X1RETFVyUdIBdkFVX3lxTE54ZUZxT09YSDBrQzZlSTk5RG41WlR5WWRPLXQxV3dZQ2UxRlByN0VfNGdSbHdwSVJlY0hfME9OSnJwaFVSY2F4SDhIVGEtczlXa0VyUi1UT3BaT2l4aXUxTXFrT3NKZGZ1OHBiUzN6ZVhtR3VybGc?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTFAxRHU5aFBscDR4ZDhLWF9NVks2WWIwcGN1eUJIeHFXLVp0WnhKVkVlX2JtaUxLZUpSNFhrcjJMbnFnUlJtT1l0b2lNdkdOWUhieENaUzNaLVlFaWw1a2VjcmVUdkpmeGhpWVB2X1RETFVyUdIBdkFVX3lxTE54ZUZxT09YSDBrQzZlSTk5RG41WlR5WWRPLXQxV3dZQ2UxRlByN0VfNGdSbHdwSVJlY0hfME9OSnJwaFVSY2F4SDhIVGEtczlXa0VyUi1UT3BaT2l4aXUxTXFrT3NKZGZ1OHBiUzN6ZVhtR3VybGc</guid><pubDate>Fri, 20 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTFAxRHU5aFBscDR4ZDhLWF9NVks2WWIwcGN1eUJIeHFXLVp0WnhKVkVlX2JtaUxLZUpSNFhrcjJMbnFnUlJtT1l0b2lNdkdOWUhieENaUzNaLVlFaWw1a2VjcmVUdkpmeGhpWVB2X1RETFVyUdIBdkFVX3lxTE54ZUZxT09YSDBrQzZlSTk5RG41WlR5WWRPLXQxV3dZQ2UxRlByN0VfNGdSbHdwSVJlY0hfME9OSnJwaFVSY2F4SDhIVGEtczlXa0VyUi1UT3BaT2l4aXUxTXFrT3NKZGZ1OHBiUzN6ZVhtR3VybGc?oc=5" target="_blank"&gt;대웅제약 성조숙증약 ‘루피어’, 시장 잔류 걸린 생동시험에 주목&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디소비자뉴스&lt;/font&gt;</description><source url="http://www.medisobizanews.com">메디소비자뉴스</source></item><item><title>올해도 ‘리바로젯’ 제네릭 도전 이어진다 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE5oQU1yQWN6cUFVR1Raall3bmNqQUh2d3FyLTNCU0NOYWJWbGg1aGwzbE16R18xRWxLTFRtblpCa1h4NG4xLS1lZmx3d2ZpMVNzWEhjNEFjWmJwb0hVb01TMUNySDJFV3RYcVE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE5oQU1yQWN6cUFVR1Raall3bmNqQUh2d3FyLTNCU0NOYWJWbGg1aGwzbE16R18xRWxLTFRtblpCa1h4NG4xLS1lZmx3d2ZpMVNzWEhjNEFjWmJwb0hVb01TMUNySDJFV3RYcVE</guid><pubDate>Tue, 17 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE5oQU1yQWN6cUFVR1Raall3bmNqQUh2d3FyLTNCU0NOYWJWbGg1aGwzbE16R18xRWxLTFRtblpCa1h4NG4xLS1lZmx3d2ZpMVNzWEhjNEFjWmJwb0hVb01TMUNySDJFV3RYcVE?oc=5" target="_blank"&gt;올해도 ‘리바로젯’ 제네릭 도전 이어진다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>대웅제약 300억대 성조숙증藥 ‘루피어데포’ 생동 결과 주목 - 시사저널e</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTE43RFJxTE1nTlR3cV92MThPR2hBc3BVZC1wS0stbzhtNTFfNDVDX0xDcjczLXZ6UnN6YnoxaTVtaHA3SU83UkpSUkU5WHd1ZFFWTkZKalpvVEVpRlpQdlVtRHVGcmgtbUxhZ2ZrUGduTVJLUdIBdkFVX3lxTFA0YmwxMU1wd19UWTNHWlBBeFRxUi1qNDZHaHozSjBzcHdjTFVYdFlqcnk5MWE0MVFZVk45Q2RLbEVoYWJSMGI0RnVIbTUxanpBVmFQeDhlMF9KOU41NEZ5SWZQSkpqM1FmS3AydWNYRnU4bV9sZGc?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTE43RFJxTE1nTlR3cV92MThPR2hBc3BVZC1wS0stbzhtNTFfNDVDX0xDcjczLXZ6UnN6YnoxaTVtaHA3SU83UkpSUkU5WHd1ZFFWTkZKalpvVEVpRlpQdlVtRHVGcmgtbUxhZ2ZrUGduTVJLUdIBdkFVX3lxTFA0YmwxMU1wd19UWTNHWlBBeFRxUi1qNDZHaHozSjBzcHdjTFVYdFlqcnk5MWE0MVFZVk45Q2RLbEVoYWJSMGI0RnVIbTUxanpBVmFQeDhlMF9KOU41NEZ5SWZQSkpqM1FmS3AydWNYRnU4bV9sZGc</guid><pubDate>Fri, 27 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTE43RFJxTE1nTlR3cV92MThPR2hBc3BVZC1wS0stbzhtNTFfNDVDX0xDcjczLXZ6UnN6YnoxaTVtaHA3SU83UkpSUkU5WHd1ZFFWTkZKalpvVEVpRlpQdlVtRHVGcmgtbUxhZ2ZrUGduTVJLUdIBdkFVX3lxTFA0YmwxMU1wd19UWTNHWlBBeFRxUi1qNDZHaHozSjBzcHdjTFVYdFlqcnk5MWE0MVFZVk45Q2RLbEVoYWJSMGI0RnVIbTUxanpBVmFQeDhlMF9KOU41NEZ5SWZQSkpqM1FmS3AydWNYRnU4bV9sZGc?oc=5" target="_blank"&gt;대웅제약 300억대 성조숙증藥 ‘루피어데포’ 생동 결과 주목&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;시사저널e&lt;/font&gt;</description><source url="https://www.sisajournal-e.com">시사저널e</source></item><item><title>식약처, 의약품 제조소 이전 시 생동시험 부담 완화 - 청년의사</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTE1KV2dxY3hyRGxyanZhRFk3UHFUY3phbDd1clJZNjhINmFNUGp1VFFlLUR4N1p5LW0tQlpzTnhRRDVoVEszNW5GbW9PMUR6Y2FkNjQ0ZENCS19iZ21JRER6QmVrRXhiR1FMV2YtS25zc9IBc0FVX3lxTE5tT290SmtfUjNhbjFpc0FKLW1zdGVkQ1F4eFhkSFpjeHU1bG0xcDhvemx1QTN6MXlOdU0xaktHYW5MLVhjdUpnT3BDc01JOTRzZDNNc1ZJbXcwSkZoS0d4SDN5TUVtaDQ0VEJZcFN6U0diUGc?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTE1KV2dxY3hyRGxyanZhRFk3UHFUY3phbDd1clJZNjhINmFNUGp1VFFlLUR4N1p5LW0tQlpzTnhRRDVoVEszNW5GbW9PMUR6Y2FkNjQ0ZENCS19iZ21JRER6QmVrRXhiR1FMV2YtS25zc9IBc0FVX3lxTE5tT290SmtfUjNhbjFpc0FKLW1zdGVkQ1F4eFhkSFpjeHU1bG0xcDhvemx1QTN6MXlOdU0xaktHYW5MLVhjdUpnT3BDc01JOTRzZDNNc1ZJbXcwSkZoS0d4SDN5TUVtaDQ0VEJZcFN6U0diUGc</guid><pubDate>Thu, 27 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE1KV2dxY3hyRGxyanZhRFk3UHFUY3phbDd1clJZNjhINmFNUGp1VFFlLUR4N1p5LW0tQlpzTnhRRDVoVEszNW5GbW9PMUR6Y2FkNjQ0ZENCS19iZ21JRER6QmVrRXhiR1FMV2YtS25zc9IBc0FVX3lxTE5tT290SmtfUjNhbjFpc0FKLW1zdGVkQ1F4eFhkSFpjeHU1bG0xcDhvemx1QTN6MXlOdU0xaktHYW5MLVhjdUpnT3BDc01JOTRzZDNNc1ZJbXcwSkZoS0d4SDN5TUVtaDQ0VEJZcFN6U0diUGc?oc=5" target="_blank"&gt;식약처, 의약품 제조소 이전 시 생동시험 부담 완화&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;청년의사&lt;/font&gt;</description><source url="http://www.docdocdoc.co.kr">청년의사</source></item><item><title>식약처, 제약사 제조소 이전 시 생동시험 부담 완화 - 병원신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE1zeWcwOVd5RExWbnhYRDdtdFNlY2YzN280d29GM2ZFSGFrbjk0MWlDQXBQeE1rTkRmX3pQdHBkX0xnWVplb19LRGNfdXgyd2paTDZKT1NWWjNlcm1wUi13VUx0dUUxclRncEE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE1zeWcwOVd5RExWbnhYRDdtdFNlY2YzN280d29GM2ZFSGFrbjk0MWlDQXBQeE1rTkRmX3pQdHBkX0xnWVplb19LRGNfdXgyd2paTDZKT1NWWjNlcm1wUi13VUx0dUUxclRncEE</guid><pubDate>Thu, 27 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE1zeWcwOVd5RExWbnhYRDdtdFNlY2YzN280d29GM2ZFSGFrbjk0MWlDQXBQeE1rTkRmX3pQdHBkX0xnWVplb19LRGNfdXgyd2paTDZKT1NWWjNlcm1wUi13VUx0dUUxclRncEE?oc=5" target="_blank"&gt;식약처, 제약사 제조소 이전 시 생동시험 부담 완화&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;병원신문&lt;/font&gt;</description><source url="https://www.khanews.com">병원신문</source></item><item><title>식약처, 藥 제조소 이전 시 생동 부담 낮춘다…업계 숙원 해결 - 메디파나뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1wNUxveWM3TEhlWnh5RzVabDVyams3MFpwaG5ua2dmUFV4MHNYYXJ1WkdpVEpiMGtLUXhGVnBBNGYwczJwSWctaHRSa2h1SVJhN2dKTWE2MjBwSG5mTXRwTnBBamRHazVfdjFJ?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1wNUxveWM3TEhlWnh5RzVabDVyams3MFpwaG5ua2dmUFV4MHNYYXJ1WkdpVEpiMGtLUXhGVnBBNGYwczJwSWctaHRSa2h1SVJhN2dKTWE2MjBwSG5mTXRwTnBBamRHazVfdjFJ</guid><pubDate>Thu, 27 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1wNUxveWM3TEhlWnh5RzVabDVyams3MFpwaG5ua2dmUFV4MHNYYXJ1WkdpVEpiMGtLUXhGVnBBNGYwczJwSWctaHRSa2h1SVJhN2dKTWE2MjBwSG5mTXRwTnBBamRHazVfdjFJ?oc=5" target="_blank"&gt;식약처, 藥 제조소 이전 시 생동 부담 낮춘다…업계 숙원 해결&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디파나뉴스&lt;/font&gt;</description><source url="https://www.medipana.com">메디파나뉴스</source></item><item><title>제조소 이전 시에도 ‘생동성자료’ 면제된다 - 후생신보</title><link>https://news.google.com/rss/articles/CBMiREFVX3lxTE5nMWFYX09PNmhRVjBaV3NBMWhON1lqeW9BQWJaTVVmZ1F3WndkcDJ2R0w0cndhcmc0UkNWUEYzVUVKVUdK?oc=5</link><guid isPermaLink="false">CBMiREFVX3lxTE5nMWFYX09PNmhRVjBaV3NBMWhON1lqeW9BQWJaTVVmZ1F3WndkcDJ2R0w0cndhcmc0UkNWUEYzVUVKVUdK</guid><pubDate>Thu, 27 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiREFVX3lxTE5nMWFYX09PNmhRVjBaV3NBMWhON1lqeW9BQWJaTVVmZ1F3WndkcDJ2R0w0cndhcmc0UkNWUEYzVUVKVUdK?oc=5" target="_blank"&gt;제조소 이전 시에도 ‘생동성자료’ 면제된다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;후생신보&lt;/font&gt;</description><source url="http://www.whosaeng.com">후생신보</source></item><item><title>펠루비 제네릭 경쟁 확대되나…대화제약도 생동시험 승인 - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTFBua2FreFhMOC0tNlF2WGRTWklXZk5sdW9nQlVQVjF1VzRmS3MySF80RnJ5RTd5SlNVWTZCR01FZ0R6TU4tOUlQUVQ2VWVrbVg0WmRLU1htcWxwUHVkbXNZbGNJWm45U0wxMlRhcHdFdHB5Zw?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTFBua2FreFhMOC0tNlF2WGRTWklXZk5sdW9nQlVQVjF1VzRmS3MySF80RnJ5RTd5SlNVWTZCR01FZ0R6TU4tOUlQUVQ2VWVrbVg0WmRLU1htcWxwUHVkbXNZbGNJWm45U0wxMlRhcHdFdHB5Zw</guid><pubDate>Mon, 17 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTFBua2FreFhMOC0tNlF2WGRTWklXZk5sdW9nQlVQVjF1VzRmS3MySF80RnJ5RTd5SlNVWTZCR01FZ0R6TU4tOUlQUVQ2VWVrbVg0WmRLU1htcWxwUHVkbXNZbGNJWm45U0wxMlRhcHdFdHB5Zw?oc=5" target="_blank"&gt;펠루비 제네릭 경쟁 확대되나…대화제약도 생동시험 승인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://www.medicaltimes.com">메디칼타임즈</source></item><item><title>제조소 주소만 바뀌어도 생동?…식약처 "경미 변경은 비교용출로 충분" - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFBpS1UzNHRoTUhZaWJjcGkwOVd6NVlRRHJvOU96UjlaOUZXNXJJSmN4MUNqX2F3UzBUMHdmZWNVdE5aTmVaSG1IS1oxdWVDbTlnWnlDRFZkQS02UG9yN0Z2dGpVSGNfdDZ4Z0dOVw?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFBpS1UzNHRoTUhZaWJjcGkwOVd6NVlRRHJvOU96UjlaOUZXNXJJSmN4MUNqX2F3UzBUMHdmZWNVdE5aTmVaSG1IS1oxdWVDbTlnWnlDRFZkQS02UG9yN0Z2dGpVSGNfdDZ4Z0dOVw</guid><pubDate>Thu, 27 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBpS1UzNHRoTUhZaWJjcGkwOVd6NVlRRHJvOU96UjlaOUZXNXJJSmN4MUNqX2F3UzBUMHdmZWNVdE5aTmVaSG1IS1oxdWVDbTlnWnlDRFZkQS02UG9yN0Z2dGpVSGNfdDZ4Z0dOVw?oc=5" target="_blank"&gt;제조소 주소만 바뀌어도 생동?…식약처 "경미 변경은 비교용출로 충분"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>공동생동 제한 부활하나…제약업계 의견차 '평행선' - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE5ZUmdldnpMQXNBOE1KMjhQR1RuXzBHMWlRcVh0bTllel9jQW1EMU4zMFFnUUR4aFhmWUdoVG9BTG5mNEJQR1BXREZmR29LeTA?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE5ZUmdldnpMQXNBOE1KMjhQR1RuXzBHMWlRcVh0bTllel9jQW1EMU4zMFFnUUR4aFhmWUdoVG9BTG5mNEJQR1BXREZmR29LeTA</guid><pubDate>Sat, 14 Mar 2026 12:21:19 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE5ZUmdldnpMQXNBOE1KMjhQR1RuXzBHMWlRcVh0bTllel9jQW1EMU4zMFFnUUR4aFhmWUdoVG9BTG5mNEJQR1BXREZmR29LeTA?oc=5" target="_blank"&gt;공동생동 제한 부활하나…제약업계 의견차 '평행선'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>식약처, 허가 후 제조법 변경 시 생동 안정성 시험기간 3개월로 변경 - 메디파나뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE5UdjhuejRMdWtMV1dxOVNPZEh4LTdyLTF4dnFMM1NFMGJlTmpsNnpVYy1qOWROSmNKN3hUYWNNUWlrZU96VXR1cE0yTk9FT1RJV1hPWVpMb0NYdGZEaWN3eF9aTzhTUDJhTUpJ?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE5UdjhuejRMdWtMV1dxOVNPZEh4LTdyLTF4dnFMM1NFMGJlTmpsNnpVYy1qOWROSmNKN3hUYWNNUWlrZU96VXR1cE0yTk9FT1RJV1hPWVpMb0NYdGZEaWN3eF9aTzhTUDJhTUpJ</guid><pubDate>Wed, 12 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5UdjhuejRMdWtMV1dxOVNPZEh4LTdyLTF4dnFMM1NFMGJlTmpsNnpVYy1qOWROSmNKN3hUYWNNUWlrZU96VXR1cE0yTk9FT1RJV1hPWVpMb0NYdGZEaWN3eF9aTzhTUDJhTUpJ?oc=5" target="_blank"&gt;식약처, 허가 후 제조법 변경 시 생동 안정성 시험기간 3개월로 변경&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디파나뉴스&lt;/font&gt;</description><source url="https://www.medipana.com">메디파나뉴스</source></item><item><title>제조소 이전시 경미한 제조방법 변경은 '비교용출'도 인정 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiVkFVX3lxTE1VNEx6Z0FKVDNXWEUtdFJvbGZFMmhDX1YyS0dibDJzMVh0Sk5zNWJUdGo4NVcySk5Gd1ZUVDBKaG1xa2FtTUJqSEhrVnRiVVVMRnZuWWN3?oc=5</link><guid isPermaLink="false">CBMiVkFVX3lxTE1VNEx6Z0FKVDNXWEUtdFJvbGZFMmhDX1YyS0dibDJzMVh0Sk5zNWJUdGo4NVcySk5Gd1ZUVDBKaG1xa2FtTUJqSEhrVnRiVVVMRnZuWWN3</guid><pubDate>Thu, 19 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE1VNEx6Z0FKVDNXWEUtdFJvbGZFMmhDX1YyS0dibDJzMVh0Sk5zNWJUdGo4NVcySk5Gd1ZUVDBKaG1xa2FtTUJqSEhrVnRiVVVMRnZuWWN3?oc=5" target="_blank"&gt;제조소 이전시 경미한 제조방법 변경은 '비교용출'도 인정&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://www.dailypharm.com">데일리팜</source></item><item><title>생동시험 기준되는 대조약 36품목 공고…5품목 미선정 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE1HOWFpcFlPeDBMWEFiWEV6RXp6SVR6NjFSaUN1aWEwNHVhc1pHOWhfWXNXZ0VXWXZfRXN6Wk9PXy1oY05teGFRaUFqcEdHVEQzQl85YXdST3lrRENzMi1yZERrZ0FfdmwyVHp3cw?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE1HOWFpcFlPeDBMWEFiWEV6RXp6SVR6NjFSaUN1aWEwNHVhc1pHOWhfWXNXZ0VXWXZfRXN6Wk9PXy1oY05teGFRaUFqcEdHVEQzQl85YXdST3lrRENzMi1yZERrZ0FfdmwyVHp3cw</guid><pubDate>Fri, 07 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1HOWFpcFlPeDBMWEFiWEV6RXp6SVR6NjFSaUN1aWEwNHVhc1pHOWhfWXNXZ0VXWXZfRXN6Wk9PXy1oY05teGFRaUFqcEdHVEQzQl85YXdST3lrRENzMi1yZERrZ0FfdmwyVHp3cw?oc=5" target="_blank"&gt;생동시험 기준되는 대조약 36품목 공고…5품목 미선정&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>"제조소 이전 경미한 변경 비교용출 대체, 시간·비용 절약" - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiYEFVX3lxTE0wMU5fOUZKVXNuZ1hXQjU2RUNlUEl6am9kZ01IVF9vbWVMR3ZmeU11dXZPVHNvVDlXWUdIMUliY0lGYVJfdE13NEJRUzNUZ3RtTkNQRFVMbDJLaUZUR21jZg?oc=5</link><guid isPermaLink="false">CBMiYEFVX3lxTE0wMU5fOUZKVXNuZ1hXQjU2RUNlUEl6am9kZ01IVF9vbWVMR3ZmeU11dXZPVHNvVDlXWUdIMUliY0lGYVJfdE13NEJRUzNUZ3RtTkNQRFVMbDJLaUZUR21jZg</guid><pubDate>Thu, 27 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE0wMU5fOUZKVXNuZ1hXQjU2RUNlUEl6am9kZ01IVF9vbWVMR3ZmeU11dXZPVHNvVDlXWUdIMUliY0lGYVJfdE13NEJRUzNUZ3RtTkNQRFVMbDJLaUZUR21jZg?oc=5" target="_blank"&gt;"제조소 이전 경미한 변경 비교용출 대체, 시간·비용 절약"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://oldm.dailypharm.com">데일리팜</source></item><item><title>식약처, "주사제 등 무균제제 원료약 종류∙농도 다르면 생동시험 자료 제출해야" - 데일리메디팜</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE1xak1MV0NxS1llUnhwR1BsZ0NEcW50WXNyc3RjTlJCSmxfa1Y5TDRac1BxWmlZU1A2ZVA3NHVfTU1HZU9kcjRKZTB6YXVHZ2lUaWwxbkdIeHk3YkhQMWYwZzRzTllKQ0VIZjNwX0tn?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE1xak1MV0NxS1llUnhwR1BsZ0NEcW50WXNyc3RjTlJCSmxfa1Y5TDRac1BxWmlZU1A2ZVA3NHVfTU1HZU9kcjRKZTB6YXVHZ2lUaWwxbkdIeHk3YkhQMWYwZzRzTllKQ0VIZjNwX0tn</guid><pubDate>Wed, 16 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1xak1MV0NxS1llUnhwR1BsZ0NEcW50WXNyc3RjTlJCSmxfa1Y5TDRac1BxWmlZU1A2ZVA3NHVfTU1HZU9kcjRKZTB6YXVHZ2lUaWwxbkdIeHk3YkhQMWYwZzRzTllKQ0VIZjNwX0tn?oc=5" target="_blank"&gt;식약처, "주사제 등 무균제제 원료약 종류∙농도 다르면 생동시험 자료 제출해야"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리메디팜&lt;/font&gt;</description><source url="http://m.dailymedipharm.com">데일리메디팜</source></item><item><title>함량다른 제제 생동시험 면제기준 강화 등 곧 시행될까 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE5Ca01kc0V6U0tnaWUtVDJBdUNNOENEMXNadXk4YnFsUHdRU0RhRVRXUG02YUZnN20tdkpNQlNhYTNaVC1kLVhob0ktc1RUbEU4cWMyYWFHZUlzNXpncDlEdmlyeWV4dkdBcURR?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE5Ca01kc0V6U0tnaWUtVDJBdUNNOENEMXNadXk4YnFsUHdRU0RhRVRXUG02YUZnN20tdkpNQlNhYTNaVC1kLVhob0ktc1RUbEU4cWMyYWFHZUlzNXpncDlEdmlyeWV4dkdBcURR</guid><pubDate>Wed, 16 Sep 2020 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5Ca01kc0V6U0tnaWUtVDJBdUNNOENEMXNadXk4YnFsUHdRU0RhRVRXUG02YUZnN20tdkpNQlNhYTNaVC1kLVhob0ktc1RUbEU4cWMyYWFHZUlzNXpncDlEdmlyeWV4dkdBcURR?oc=5" target="_blank"&gt;함량다른 제제 생동시험 면제기준 강화 등 곧 시행될까&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>생약제제 생동시험 의무화가 부른 소송… '대안 없는' 식약처 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1KZXVZdlUxTGpxbGx0eFhVWlpjSUcza1lmVGcxR2oyWUVUMGZVSmMwZDY1eVZESGpNdjNlbmtxNUtROHVCaEdrM3IxZkF3dUtGRW91UVg4azRSNEpoQmpKT0hzNUR6ZF9CQnZv?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1KZXVZdlUxTGpxbGx0eFhVWlpjSUcza1lmVGcxR2oyWUVUMGZVSmMwZDY1eVZESGpNdjNlbmtxNUtROHVCaEdrM3IxZkF3dUtGRW91UVg4azRSNEpoQmpKT0hzNUR6ZF9CQnZv</guid><pubDate>Mon, 26 Feb 2024 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1KZXVZdlUxTGpxbGx0eFhVWlpjSUcza1lmVGcxR2oyWUVUMGZVSmMwZDY1eVZESGpNdjNlbmtxNUtROHVCaEdrM3IxZkF3dUtGRW91UVg4azRSNEpoQmpKT0hzNUR6ZF9CQnZv?oc=5" target="_blank"&gt;생약제제 생동시험 의무화가 부른 소송… '대안 없는' 식약처&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>[Generic Trend] 린버크 제네릭 도전 제약사, 제품 개발 본격화 - PRESS9</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTE9SLWZrTEZRMFh6Z21oQ3cyeXd3aUh2QTNiZkJmd2pjTkd2Wk9IbTIyRG1yQV8zbk92S2RGUmVLZDVjV1FGREZtcV9xYk1HaDRnQktQRXNrU0RjanNrWFVzTW5wVm9HUQ?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTE9SLWZrTEZRMFh6Z21oQ3cyeXd3aUh2QTNiZkJmd2pjTkd2Wk9IbTIyRG1yQV8zbk92S2RGUmVLZDVjV1FGREZtcV9xYk1HaDRnQktQRXNrU0RjanNrWFVzTW5wVm9HUQ</guid><pubDate>Tue, 04 Nov 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE9SLWZrTEZRMFh6Z21oQ3cyeXd3aUh2QTNiZkJmd2pjTkd2Wk9IbTIyRG1yQV8zbk92S2RGUmVLZDVjV1FGREZtcV9xYk1HaDRnQktQRXNrU0RjanNrWFVzTW5wVm9HUQ?oc=5" target="_blank"&gt;[Generic Trend] 린버크 제네릭 도전 제약사, 제품 개발 본격화&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PRESS9&lt;/font&gt;</description><source url="https://www.press9.kr">PRESS9</source></item><item><title>내년부터 경구 고형제·무균제도 생동시험 대상 확대 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE5jOXkwWERTRDYzb29Lc292MUJKMzBacGpuckJPWWNEdlU4X2ctb1dPdkE5dWl2djlOR25mU09DVHR4R21VMkxUSk5UTXhXYXd6SDA4N2lRSmVwb0NTa2xhSVU0N01xQWQwZG1n?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE5jOXkwWERTRDYzb29Lc292MUJKMzBacGpuckJPWWNEdlU4X2ctb1dPdkE5dWl2djlOR25mU09DVHR4R21VMkxUSk5UTXhXYXd6SDA4N2lRSmVwb0NTa2xhSVU0N01xQWQwZG1n</guid><pubDate>Tue, 13 Apr 2021 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5jOXkwWERTRDYzb29Lc292MUJKMzBacGpuckJPWWNEdlU4X2ctb1dPdkE5dWl2djlOR25mU09DVHR4R21VMkxUSk5UTXhXYXd6SDA4N2lRSmVwb0NTa2xhSVU0N01xQWQwZG1n?oc=5" target="_blank"&gt;내년부터 경구 고형제·무균제도 생동시험 대상 확대&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>의약품 변경허가시 대조약으로 생동시험 의무화 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE9fX3BkakI4ZTBoMGd2YXJncFRycXlrUGNoMDZRalVsTmNTSi1ndEVhV0J3dERja1JxNmxOaXMwVG5aaWc2R2QxNzRWY182WW9aR3BjTGxIWGxMLXhFeXlKNENvWlkxTkMzYkNr?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE9fX3BkakI4ZTBoMGd2YXJncFRycXlrUGNoMDZRalVsTmNTSi1ndEVhV0J3dERja1JxNmxOaXMwVG5aaWc2R2QxNzRWY182WW9aR3BjTGxIWGxMLXhFeXlKNENvWlkxTkMzYkNr</guid><pubDate>Fri, 05 Mar 2021 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9fX3BkakI4ZTBoMGd2YXJncFRycXlrUGNoMDZRalVsTmNTSi1ndEVhV0J3dERja1JxNmxOaXMwVG5aaWc2R2QxNzRWY182WW9aR3BjTGxIWGxMLXhFeXlKNENvWlkxTkMzYkNr?oc=5" target="_blank"&gt;의약품 변경허가시 대조약으로 생동시험 의무화&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>경구용액제, 시럽제 등 15일부터 생동시험 의무 시행 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE5BdlJyN0ZfZUY2M3R3cFVkaTNrR2w5R2VaV1ZueDlDRFhzTjFpSzR3bmZIOVZ0cVFaalM3UTFiR2xZck5XRkxUdFhiUmEtUEdwUHZsZ1o2VGRKYVJ5TzVtQWZQc3ZnT2VqdmNN?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE5BdlJyN0ZfZUY2M3R3cFVkaTNrR2w5R2VaV1ZueDlDRFhzTjFpSzR3bmZIOVZ0cVFaalM3UTFiR2xZck5XRkxUdFhiUmEtUEdwUHZsZ1o2VGRKYVJ5TzVtQWZQc3ZnT2VqdmNN</guid><pubDate>Tue, 12 Apr 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5BdlJyN0ZfZUY2M3R3cFVkaTNrR2w5R2VaV1ZueDlDRFhzTjFpSzR3bmZIOVZ0cVFaalM3UTFiR2xZck5XRkxUdFhiUmEtUEdwUHZsZ1o2VGRKYVJ5TzVtQWZQc3ZnT2VqdmNN?oc=5" target="_blank"&gt;경구용액제, 시럽제 등 15일부터 생동시험 의무 시행&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>약가 재평가 임박했는데...확진자 급증에 생동시험 난항 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE1kUkxCRzN3OU9IVWJZcXFrV3VoeVlFSEJzbXZub2JyM2w5SWR3VXYyTkN4bDl6eURZYk0wbUtpLTFYMEVNeTdJU215bVdnMXM?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE1kUkxCRzN3OU9IVWJZcXFrV3VoeVlFSEJzbXZub2JyM2w5SWR3VXYyTkN4bDl6eURZYk0wbUtpLTFYMEVNeTdJU215bVdnMXM</guid><pubDate>Fri, 08 Apr 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE1kUkxCRzN3OU9IVWJZcXFrV3VoeVlFSEJzbXZub2JyM2w5SWR3VXYyTkN4bDl6eURZYk0wbUtpLTFYMEVNeTdJU215bVdnMXM?oc=5" target="_blank"&gt;약가 재평가 임박했는데...확진자 급증에 생동시험 난항&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>생동시험 어려운 '생약제제' 재평가 실시...10월 공고 예정 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE9XNnF6LUZfeHFlM3MtTVg4cU1LX2I4Um9tVFpLc0pManFpQjlweUlqcVk3eDM5c0l3QUZSanlMTEx3dXJsbGRISGxaQkU4SlROTWVHaVJNNG4xZzBwUElyUmNZd3BRSGNKLVB3?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE9XNnF6LUZfeHFlM3MtTVg4cU1LX2I4Um9tVFpLc0pManFpQjlweUlqcVk3eDM5c0l3QUZSanlMTEx3dXJsbGRISGxaQkU4SlROTWVHaVJNNG4xZzBwUElyUmNZd3BRSGNKLVB3</guid><pubDate>Mon, 10 Jun 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9XNnF6LUZfeHFlM3MtTVg4cU1LX2I4Um9tVFpLc0pManFpQjlweUlqcVk3eDM5c0l3QUZSanlMTEx3dXJsbGRISGxaQkU4SlROTWVHaVJNNG4xZzBwUElyUmNZd3BRSGNKLVB3?oc=5" target="_blank"&gt;생동시험 어려운 '생약제제' 재평가 실시...10월 공고 예정&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>앗, 자체 생동시험했는데 허가증이 없다고? - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTFA2V1JGeVRnbnNCSGR3YjQ4N1lTV2JJNVkzNlJMREtJY3ZJOW5RUE81UkVudUlBRV9Ldm5jZ3hBQk5VSkI1SWJlS0thbFFLRlJyUkVoN0o2R0hLc3hHSUF0b05wRFdxQzhMakE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTFA2V1JGeVRnbnNCSGR3YjQ4N1lTV2JJNVkzNlJMREtJY3ZJOW5RUE81UkVudUlBRV9Ldm5jZ3hBQk5VSkI1SWJlS0thbFFLRlJyUkVoN0o2R0hLc3hHSUF0b05wRFdxQzhMakE</guid><pubDate>Fri, 12 Aug 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFA2V1JGeVRnbnNCSGR3YjQ4N1lTV2JJNVkzNlJMREtJY3ZJOW5RUE81UkVudUlBRV9Ldm5jZ3hBQk5VSkI1SWJlS0thbFFLRlJyUkVoN0o2R0hLc3hHSUF0b05wRFdxQzhMakE?oc=5" target="_blank"&gt;앗, 자체 생동시험했는데 허가증이 없다고?&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="http://www.hitnews.co.kr">히트뉴스</source></item><item><title>"위탁제네릭 생동시험 어떡할까"...애타는 제약사들 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiXEFVX3lxTFB5dFdhODVNbmxmaWVkVWFvaEJ5WXRrWkdUYmhqZ3FVVTFTckxZTkRuN3pKQkJkbVJmVTQtVW5IOXk5S29oMmNSNTNCV21BR1RHc0J2YnMzRFVxQlRG?oc=5</link><guid isPermaLink="false">CBMiXEFVX3lxTFB5dFdhODVNbmxmaWVkVWFvaEJ5WXRrWkdUYmhqZ3FVVTFTckxZTkRuN3pKQkJkbVJmVTQtVW5IOXk5S29oMmNSNTNCV21BR1RHc0J2YnMzRFVxQlRG</guid><pubDate>Mon, 06 Jul 2020 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTFB5dFdhODVNbmxmaWVkVWFvaEJ5WXRrWkdUYmhqZ3FVVTFTckxZTkRuN3pKQkJkbVJmVTQtVW5IOXk5S29oMmNSNTNCV21BR1RHc0J2YnMzRFVxQlRG?oc=5" target="_blank"&gt;"위탁제네릭 생동시험 어떡할까"...애타는 제약사들&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://m.dailypharm.com">데일리팜</source></item><item><title>엔트레스토 생동 재도전 나선 종근당…무엇을 노리나 - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMicEFVX3lxTE9VY2hva29vUnNRdFNWV0RtUzRUQ1hsRHNXTjVLbnE2eUVLVVNPaXhMeWpkR0ZUMDYtMWdUTWhCZkZCdVV0Y05UdnlMNVYyWExubEQyWDdzRlBfTG4yRmJPbEhvNE1XN0dDRllNNEFLMFA?oc=5</link><guid isPermaLink="false">CBMicEFVX3lxTE9VY2hva29vUnNRdFNWV0RtUzRUQ1hsRHNXTjVLbnE2eUVLVVNPaXhMeWpkR0ZUMDYtMWdUTWhCZkZCdVV0Y05UdnlMNVYyWExubEQyWDdzRlBfTG4yRmJPbEhvNE1XN0dDRllNNEFLMFA</guid><pubDate>Fri, 01 Aug 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE9VY2hva29vUnNRdFNWV0RtUzRUQ1hsRHNXTjVLbnE2eUVLVVNPaXhMeWpkR0ZUMDYtMWdUTWhCZkZCdVV0Y05UdnlMNVYyWExubEQyWDdzRlBfTG4yRmJPbEhvNE1XN0dDRllNNEFLMFA?oc=5" target="_blank"&gt;엔트레스토 생동 재도전 나선 종근당…무엇을 노리나&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://www.medicaltimes.com">메디칼타임즈</source></item><item><title>"케이캡 잡아라" 국내 제약사들 P-CAB 시장 연이어 도전장 - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE1MRlBiVGhtY3U1emJldnByVmUxeGlWWXVHbEFjV3pINmZ3V0dzejlxMnNfUDA5WVUyT21vSXM1SWxkUWtGX0xMZEc3ckx6bEdOclpBSzVsQUktNnpLbVhfUkctNnFRenYzd2VSSDNpbzhrSTg?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE1MRlBiVGhtY3U1emJldnByVmUxeGlWWXVHbEFjV3pINmZ3V0dzejlxMnNfUDA5WVUyT21vSXM1SWxkUWtGX0xMZEc3ckx6bEdOclpBSzVsQUktNnpLbVhfUkctNnFRenYzd2VSSDNpbzhrSTg</guid><pubDate>Tue, 02 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE1MRlBiVGhtY3U1emJldnByVmUxeGlWWXVHbEFjV3pINmZ3V0dzejlxMnNfUDA5WVUyT21vSXM1SWxkUWtGX0xMZEc3ckx6bEdOclpBSzVsQUktNnpLbVhfUkctNnFRenYzd2VSSDNpbzhrSTg?oc=5" target="_blank"&gt;"케이캡 잡아라" 국내 제약사들 P-CAB 시장 연이어 도전장&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://www.medicaltimes.com">메디칼타임즈</source></item><item><title>의약품동등성 재평가 임박... 제약사 '생동일정' 조율에 분주 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE5xZy0tU0QtUUlpM1BrYVNuU3Zid2FVN1dvU2xVQlJFUndwUDFFbGxUMzA1bmJOalBENDZ3SVg0ZXhwdHlzNWRfR01wTUI3TERUV0pvVGxfSlE0NjJjQTlmUFJjbW9qcERyYU9F?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE5xZy0tU0QtUUlpM1BrYVNuU3Zid2FVN1dvU2xVQlJFUndwUDFFbGxUMzA1bmJOalBENDZ3SVg0ZXhwdHlzNWRfR01wTUI3TERUV0pvVGxfSlE0NjJjQTlmUFJjbW9qcERyYU9F</guid><pubDate>Thu, 03 Mar 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5xZy0tU0QtUUlpM1BrYVNuU3Zid2FVN1dvU2xVQlJFUndwUDFFbGxUMzA1bmJOalBENDZ3SVg0ZXhwdHlzNWRfR01wTUI3TERUV0pvVGxfSlE0NjJjQTlmUFJjbW9qcERyYU9F?oc=5" target="_blank"&gt;의약품동등성 재평가 임박... 제약사 '생동일정' 조율에 분주&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>'공동생동' '위탁생동'의 차이점, 진짜로 아십니까? - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFBPNEM0ZDd6cVprZlhRRVZ3TEI2NUZyTEFNanhKWnphOC13d3g1aVN6aC1rZ3NtNUx1ZWh4SGRYeUx3WkV5WjdZanhHNkI0cFFQaERiMUtPd2NlM1hDRjVnUHBvM281WmhKRnJZ?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFBPNEM0ZDd6cVprZlhRRVZ3TEI2NUZyTEFNanhKWnphOC13d3g1aVN6aC1rZ3NtNUx1ZWh4SGRYeUx3WkV5WjdZanhHNkI0cFFQaERiMUtPd2NlM1hDRjVnUHBvM281WmhKRnJZ</guid><pubDate>Wed, 11 Nov 2020 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBPNEM0ZDd6cVprZlhRRVZ3TEI2NUZyTEFNanhKWnphOC13d3g1aVN6aC1rZ3NtNUx1ZWh4SGRYeUx3WkV5WjdZanhHNkI0cFFQaERiMUtPd2NlM1hDRjVnUHBvM281WmhKRnJZ?oc=5" target="_blank"&gt;'공동생동' '위탁생동'의 차이점, 진짜로 아십니까?&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>생물학적동등성 시험에 여성 비중이 증가했다는데... - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE5SUDVPSGI1blpvVFBwY3J5U09ETVJiMGRHb3lMVzM4WERodVZtSXprQjJxSlhUaEdGMldpV2pjaWoweEllc0w3ay1VdlhqX2FZQW91S2h0WWtrQWRISU83amxQN2RWd1RuUWc?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE5SUDVPSGI1blpvVFBwY3J5U09ETVJiMGRHb3lMVzM4WERodVZtSXprQjJxSlhUaEdGMldpV2pjaWoweEllc0w3ay1VdlhqX2FZQW91S2h0WWtrQWRISU83amxQN2RWd1RuUWc</guid><pubDate>Thu, 27 Jan 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE5SUDVPSGI1blpvVFBwY3J5U09ETVJiMGRHb3lMVzM4WERodVZtSXprQjJxSlhUaEdGMldpV2pjaWoweEllc0w3ay1VdlhqX2FZQW91S2h0WWtrQWRISU83amxQN2RWd1RuUWc?oc=5" target="_blank"&gt;생물학적동등성 시험에 여성 비중이 증가했다는데...&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="http://www.hitnews.co.kr">히트뉴스</source></item><item><title>의약품 동등성 가이드라인 개정, 시험·대조약 '염' 달라도 생동 면제 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1JZG8tQ3hOZzN4MXA1SGw5Q2daYjl0d25ldXJNZG9wb01RWWJ1bnFKOHUtUzh2R3o1NjJWbVdGSjdlcDhldWJBbHQtZExtNklRZUNwNUFkMnh4QmxxTDVwZHVyTUJ2T3VDR25F?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1JZG8tQ3hOZzN4MXA1SGw5Q2daYjl0d25ldXJNZG9wb01RWWJ1bnFKOHUtUzh2R3o1NjJWbVdGSjdlcDhldWJBbHQtZExtNklRZUNwNUFkMnh4QmxxTDVwZHVyTUJ2T3VDR25F</guid><pubDate>Tue, 08 Aug 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1JZG8tQ3hOZzN4MXA1SGw5Q2daYjl0d25ldXJNZG9wb01RWWJ1bnFKOHUtUzh2R3o1NjJWbVdGSjdlcDhldWJBbHQtZExtNklRZUNwNUFkMnh4QmxxTDVwZHVyTUJ2T3VDR25F?oc=5" target="_blank"&gt;의약품 동등성 가이드라인 개정, 시험·대조약 '염' 달라도 생동 면제&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>임상비용 폭등...공동개발 규제완화 목소리 커진다 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiTkFVX3lxTE5YelVUZmQ3LWhadTNPdllOd295ZFFGTS1FMDlWVmZZWHhnazhQeDFCR2tjZVVDaURSUEgyNkI0TmlnMlVESWoxX0xOMGNsZw?oc=5</link><guid isPermaLink="false">CBMiTkFVX3lxTE5YelVUZmQ3LWhadTNPdllOd295ZFFGTS1FMDlWVmZZWHhnazhQeDFCR2tjZVVDaURSUEgyNkI0TmlnMlVESWoxX0xOMGNsZw</guid><pubDate>Mon, 28 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiTkFVX3lxTE5YelVUZmQ3LWhadTNPdllOd295ZFFGTS1FMDlWVmZZWHhnazhQeDFCR2tjZVVDaURSUEgyNkI0TmlnMlVESWoxX0xOMGNsZw?oc=5" target="_blank"&gt;임상비용 폭등...공동개발 규제완화 목소리 커진다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>"생동시험 아닌 비교용출시험 자료로도 기준요건 충족?" - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTFBNLUNwdWZfa0x5NENoaHVEVFVvRlhKZHVlU3FwckNLeHdMaVA1WHY1S0VJRTJUV2pqcVhiZmlJcnRpai1CZV9sWUpQNHJJVnpDY1ZBNko3Rm5rb0d2bHRlSEhLV1lUcjFWUEE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTFBNLUNwdWZfa0x5NENoaHVEVFVvRlhKZHVlU3FwckNLeHdMaVA1WHY1S0VJRTJUV2pqcVhiZmlJcnRpai1CZV9sWUpQNHJJVnpDY1ZBNko3Rm5rb0d2bHRlSEhLV1lUcjFWUEE</guid><pubDate>Wed, 01 Jul 2020 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBNLUNwdWZfa0x5NENoaHVEVFVvRlhKZHVlU3FwckNLeHdMaVA1WHY1S0VJRTJUV2pqcVhiZmlJcnRpai1CZV9sWUpQNHJJVnpDY1ZBNko3Rm5rb0d2bHRlSEhLV1lUcjFWUEE?oc=5" target="_blank"&gt;"생동시험 아닌 비교용출시험 자료로도 기준요건 충족?"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="http://www.hitnews.co.kr">히트뉴스</source></item><item><title>삼천당제약, 경구용 GLP-1 제네릭 생동시험 성공 - seoulwire.com</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1hLVZ6amVyc1JYRk5peDdnLVdOcnhKUE12dWZYb0N6M09wYnRJYzA2Tm1iLVdaXzItVEF2NGtaVUs0YTRGaGU2OWlOZTZKeWMyb2hYNXBuVjJKaXBmZzZ3cF9Qb1ZjbEFKWUlv?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1hLVZ6amVyc1JYRk5peDdnLVdOcnhKUE12dWZYb0N6M09wYnRJYzA2Tm1iLVdaXzItVEF2NGtaVUs0YTRGaGU2OWlOZTZKeWMyb2hYNXBuVjJKaXBmZzZ3cF9Qb1ZjbEFKWUlv</guid><pubDate>Wed, 23 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1hLVZ6amVyc1JYRk5peDdnLVdOcnhKUE12dWZYb0N6M09wYnRJYzA2Tm1iLVdaXzItVEF2NGtaVUs0YTRGaGU2OWlOZTZKeWMyb2hYNXBuVjJKaXBmZzZ3cF9Qb1ZjbEFKWUlv?oc=5" target="_blank"&gt;삼천당제약, 경구용 GLP-1 제네릭 생동시험 성공&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;seoulwire.com&lt;/font&gt;</description><source url="http://www.seoulwire.com">seoulwire.com</source></item><item><title>공동생동 1+3 품목 제한이후 제약사 단독 생동시험 급증 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE13MUtHN1FxTjg5dkx5VGpCTkhwQW90Slk4Wllxem9LenpENzNxVUpIdzVSb0MzRFZVNEdDSGE4UnNJOC1vSXU0T2hOWThkdXo5cVk3V3hEdkV2VkprbmlNLXFxYmd6cWNhcVM4?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE13MUtHN1FxTjg5dkx5VGpCTkhwQW90Slk4Wllxem9LenpENzNxVUpIdzVSb0MzRFZVNEdDSGE4UnNJOC1vSXU0T2hOWThkdXo5cVk3V3hEdkV2VkprbmlNLXFxYmd6cWNhcVM4</guid><pubDate>Fri, 19 Nov 2021 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE13MUtHN1FxTjg5dkx5VGpCTkhwQW90Slk4Wllxem9LenpENzNxVUpIdzVSb0MzRFZVNEdDSGE4UnNJOC1vSXU0T2hOWThkdXo5cVk3V3hEdkV2VkprbmlNLXFxYmd6cWNhcVM4?oc=5" target="_blank"&gt;공동생동 1+3 품목 제한이후 제약사 단독 생동시험 급증&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>의약품동등성시험기준 개정...장용성제제 식후 생동추가 - 뉴스더보이스헬스케어</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTE42WjB4eWdBWGQzN04xQ0FPdHI5MXJjdktkXzIweG1FVHF6MWgwUHZjSHlVcmFWZzZxa2phR3ROMml5NV9XUmFBNklYazNBY3dlR3NmZ3NyTnU2V0pCbFo5d1pCSlRkbWFjTV9FYWluNA?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTE42WjB4eWdBWGQzN04xQ0FPdHI5MXJjdktkXzIweG1FVHF6MWgwUHZjSHlVcmFWZzZxa2phR3ROMml5NV9XUmFBNklYazNBY3dlR3NmZ3NyTnU2V0pCbFo5d1pCSlRkbWFjTV9FYWluNA</guid><pubDate>Tue, 15 Nov 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE42WjB4eWdBWGQzN04xQ0FPdHI5MXJjdktkXzIweG1FVHF6MWgwUHZjSHlVcmFWZzZxa2phR3ROMml5NV9XUmFBNklYazNBY3dlR3NmZ3NyTnU2V0pCbFo5d1pCSlRkbWFjTV9FYWluNA?oc=5" target="_blank"&gt;의약품동등성시험기준 개정...장용성제제 식후 생동추가&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴스더보이스헬스케어&lt;/font&gt;</description><source url="https://www.newsthevoice.com">뉴스더보이스헬스케어</source></item><item><title>팜젠사이언스, 제네릭 생동시험서 19개 성분 29품목 동등성 확인 - 메디포뉴스</title><link>https://news.google.com/rss/articles/CBMiZEFVX3lxTE9hY2tzNzBlcWNac1BjSXZ1V0tnOU1sczQ5am05cHhUWGJtNkdiZ05qRjU0dTJpcFVfN19kd0dzRkQtVDhNR3V4d2M3X21xZ0YxdGJtc3dQcFB6c01veGEyMkpJU3k?oc=5</link><guid isPermaLink="false">CBMiZEFVX3lxTE9hY2tzNzBlcWNac1BjSXZ1V0tnOU1sczQ5am05cHhUWGJtNkdiZ05qRjU0dTJpcFVfN19kd0dzRkQtVDhNR3V4d2M3X21xZ0YxdGJtc3dQcFB6c01veGEyMkpJU3k</guid><pubDate>Tue, 23 Aug 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE9hY2tzNzBlcWNac1BjSXZ1V0tnOU1sczQ5am05cHhUWGJtNkdiZ05qRjU0dTJpcFVfN19kd0dzRkQtVDhNR3V4d2M3X21xZ0YxdGJtc3dQcFB6c01veGEyMkpJU3k?oc=5" target="_blank"&gt;팜젠사이언스, 제네릭 생동시험서 19개 성분 29품목 동등성 확인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디포뉴스&lt;/font&gt;</description><source url="https://www.medifonews.com">메디포뉴스</source></item><item><title>허가났던 품목 생동 후 변경허가 할 때 '1+3 제한' 논란 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE1HbVYya05FV002aXk5dG9JbXVvRzFPMGxoOFJwQVZBcjlYWndVaU90Xy02WDJzcE9iSkZWRHFzVzY3eUpuRmhtY1RpN1JTV2lCRjZRQ3BjOVZGNHhVYjRpVGFYNGV1cHZxX3c?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE1HbVYya05FV002aXk5dG9JbXVvRzFPMGxoOFJwQVZBcjlYWndVaU90Xy02WDJzcE9iSkZWRHFzVzY3eUpuRmhtY1RpN1JTV2lCRjZRQ3BjOVZGNHhVYjRpVGFYNGV1cHZxX3c</guid><pubDate>Wed, 30 Nov 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE1HbVYya05FV002aXk5dG9JbXVvRzFPMGxoOFJwQVZBcjlYWndVaU90Xy02WDJzcE9iSkZWRHFzVzY3eUpuRmhtY1RpN1JTV2lCRjZRQ3BjOVZGNHhVYjRpVGFYNGV1cHZxX3c?oc=5" target="_blank"&gt;허가났던 품목 생동 후 변경허가 할 때 '1+3 제한' 논란&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="http://www.hitnews.co.kr">히트뉴스</source></item><item><title>생동 대상에 모든 전문약 포함...내달 15일 경구제 적용 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE1Ta0JycmVvbFRpZ1pYUWFtdEpURXZRWnZHaTNKelNOUFozZ0RiMEVmQWhWQWh4SUt3SkpDLWJ0LWxLT3NfY2VoNXFXWDJzZ0YteHhJQmNEclk5SnFUQmNSbkFkVkpGY09GRmpKbEtR?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE1Ta0JycmVvbFRpZ1pYUWFtdEpURXZRWnZHaTNKelNOUFozZ0RiMEVmQWhWQWh4SUt3SkpDLWJ0LWxLT3NfY2VoNXFXWDJzZ0YteHhJQmNEclk5SnFUQmNSbkFkVkpGY09GRmpKbEtR</guid><pubDate>Sat, 18 Jun 2022 19:41:33 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1Ta0JycmVvbFRpZ1pYUWFtdEpURXZRWnZHaTNKelNOUFozZ0RiMEVmQWhWQWh4SUt3SkpDLWJ0LWxLT3NfY2VoNXFXWDJzZ0YteHhJQmNEclk5SnFUQmNSbkFkVkpGY09GRmpKbEtR?oc=5" target="_blank"&gt;생동 대상에 모든 전문약 포함...내달 15일 경구제 적용&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://www.dailypharm.com">데일리팜</source></item><item><title>알리코제약, 자사 품목 첫 해외 생동시험 성공 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE9IdHYzcWdwSXJoUVBIRmVwR3pxM3o0MkhoUWlXbk1zSjczVXp5RDNjOTgtZjF6dXQzV0hrMmJzSXl2TlVLNGpuOWx1ZHhCdmlFYjd3RlRoUjlVTjZRY2VkQ0FDM1VIQkY1Tl9jT1J3?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE9IdHYzcWdwSXJoUVBIRmVwR3pxM3o0MkhoUWlXbk1zSjczVXp5RDNjOTgtZjF6dXQzV0hrMmJzSXl2TlVLNGpuOWx1ZHhCdmlFYjd3RlRoUjlVTjZRY2VkQ0FDM1VIQkY1Tl9jT1J3</guid><pubDate>Tue, 15 Apr 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE9IdHYzcWdwSXJoUVBIRmVwR3pxM3o0MkhoUWlXbk1zSjczVXp5RDNjOTgtZjF6dXQzV0hrMmJzSXl2TlVLNGpuOWx1ZHhCdmlFYjd3RlRoUjlVTjZRY2VkQ0FDM1VIQkY1Tl9jT1J3?oc=5" target="_blank"&gt;알리코제약, 자사 품목 첫 해외 생동시험 성공&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://www.dailypharm.com">데일리팜</source></item><item><title>기등재약 재평가, '생동확대품목' 자료제출 5개월 유예 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE8xR3hkaEZJazlBd3NnNmdKUUcyYW90Z3JiS09YX1QzV3pWM2ZCalVQMXFZUHBzVE9kSm1aYV9pQXhITnBRWVJxSDQtYmVOczBxNmhvZjdNN1hycnlkZk5IcndzOFk4b3hFNmc?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE8xR3hkaEZJazlBd3NnNmdKUUcyYW90Z3JiS09YX1QzV3pWM2ZCalVQMXFZUHBzVE9kSm1aYV9pQXhITnBRWVJxSDQtYmVOczBxNmhvZjdNN1hycnlkZk5IcndzOFk4b3hFNmc</guid><pubDate>Tue, 30 Aug 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE8xR3hkaEZJazlBd3NnNmdKUUcyYW90Z3JiS09YX1QzV3pWM2ZCalVQMXFZUHBzVE9kSm1aYV9pQXhITnBRWVJxSDQtYmVOczBxNmhvZjdNN1hycnlkZk5IcndzOFk4b3hFNmc?oc=5" target="_blank"&gt;기등재약 재평가, '생동확대품목' 자료제출 5개월 유예&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="http://www.hitnews.co.kr">히트뉴스</source></item><item><title>"생동 품목과 '주성분 함량' 다른 고형제 개발시 참고하세요" - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE5PU2huQU1tT2ZDemtCSjVtRmNBNnMwcDJYSnQ3WVdSUWdJOVJqb1FxdEMtcVlOZ1VYMXZ6Z2tPZUExMnBIQ0ZNdXBaZXFIRnNEcHZ3M0dpNk1xa2xGVFBkOTdBaVZtMHpNSncw?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE5PU2huQU1tT2ZDemtCSjVtRmNBNnMwcDJYSnQ3WVdSUWdJOVJqb1FxdEMtcVlOZ1VYMXZ6Z2tPZUExMnBIQ0ZNdXBaZXFIRnNEcHZ3M0dpNk1xa2xGVFBkOTdBaVZtMHpNSncw</guid><pubDate>Wed, 13 Mar 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5PU2huQU1tT2ZDemtCSjVtRmNBNnMwcDJYSnQ3WVdSUWdJOVJqb1FxdEMtcVlOZ1VYMXZ6Z2tPZUExMnBIQ0ZNdXBaZXFIRnNEcHZ3M0dpNk1xa2xGVFBkOTdBaVZtMHpNSncw?oc=5" target="_blank"&gt;"생동 품목과 '주성분 함량' 다른 고형제 개발시 참고하세요"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>올해만 3번째...P-CAB 제제 '보노프라잔' 생동시험 승인 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE12dDQ1OWtjUk4wZmNDZ0d0R1U1YWZPeEh4VUFGby01UVBVbGZMaGtHOFVtQ0tuZFpBT25ORlJVakhQVGgtQXpGQ2dnc3RyczQ?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE12dDQ1OWtjUk4wZmNDZ0d0R1U1YWZPeEh4VUFGby01UVBVbGZMaGtHOFVtQ0tuZFpBT25ORlJVakhQVGgtQXpGQ2dnc3RyczQ</guid><pubDate>Wed, 17 Apr 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE12dDQ1OWtjUk4wZmNDZ0d0R1U1YWZPeEh4VUFGby01UVBVbGZMaGtHOFVtQ0tuZFpBT25ORlJVakhQVGgtQXpGQ2dnc3RyczQ?oc=5" target="_blank"&gt;올해만 3번째...P-CAB 제제 '보노프라잔' 생동시험 승인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>식약처, 무균제제 동등성 재평가 ‘’26~’28년 시행 - 후생신보</title><link>https://news.google.com/rss/articles/CBMiREFVX3lxTE5jMXpMRVBZc19zZHhMZTE1U2NISDY0MC1jRDJaOFowUXJtRXp0UUE3OXV0NG1qMjgtT0I1ZC1FeEtmLWdW?oc=5</link><guid isPermaLink="false">CBMiREFVX3lxTE5jMXpMRVBZc19zZHhMZTE1U2NISDY0MC1jRDJaOFowUXJtRXp0UUE3OXV0NG1qMjgtT0I1ZC1FeEtmLWdW</guid><pubDate>Wed, 16 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiREFVX3lxTE5jMXpMRVBZc19zZHhMZTE1U2NISDY0MC1jRDJaOFowUXJtRXp0UUE3OXV0NG1qMjgtT0I1ZC1FeEtmLWdW?oc=5" target="_blank"&gt;식약처, 무균제제 동등성 재평가 ‘’26~’28년 시행&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;후생신보&lt;/font&gt;</description><source url="http://www.whosaeng.com">후생신보</source></item><item><title>생동성 시험 생태계 속 '중소병원-제약사' 공존관계 주목 - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE84aWpkdURFcmtYVFV0U21kb1dLVU9uSnQtaUNMY1VORzBzZU9YbmN5dXFCNXF2M0I4bXFoY2tSaHFSNTFCUGRmUk5jaUwyeE5QMXQ0SVRvLXZ3cmNUbjY4RjhFNXVxZlplMnVPMTRRNHlSN1k?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE84aWpkdURFcmtYVFV0U21kb1dLVU9uSnQtaUNMY1VORzBzZU9YbmN5dXFCNXF2M0I4bXFoY2tSaHFSNTFCUGRmUk5jaUwyeE5QMXQ0SVRvLXZ3cmNUbjY4RjhFNXVxZlplMnVPMTRRNHlSN1k</guid><pubDate>Mon, 30 Jan 2023 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE84aWpkdURFcmtYVFV0U21kb1dLVU9uSnQtaUNMY1VORzBzZU9YbmN5dXFCNXF2M0I4bXFoY2tSaHFSNTFCUGRmUk5jaUwyeE5QMXQ0SVRvLXZ3cmNUbjY4RjhFNXVxZlplMnVPMTRRNHlSN1k?oc=5" target="_blank"&gt;생동성 시험 생태계 속 '중소병원-제약사' 공존관계 주목&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://www.medicaltimes.com">메디칼타임즈</source></item><item><title>비급여 '입덧 치료제', 급여 추진 중 만난 '생동시험 복병' - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1aOE5XX2Y1N09fcEthMXdUQkw5M215QTVRbkdCQlYxVDdWa0RuMndXaktVR0JmeGNKOW5zMzRkaWtpSW5HV3dpVkRLMGJZTUx6YjlNelBOS0pScVFubWpKYVNwWW12NzJxZmFv?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1aOE5XX2Y1N09fcEthMXdUQkw5M215QTVRbkdCQlYxVDdWa0RuMndXaktVR0JmeGNKOW5zMzRkaWtpSW5HV3dpVkRLMGJZTUx6YjlNelBOS0pScVFubWpKYVNwWW12NzJxZmFv</guid><pubDate>Thu, 01 Feb 2024 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1aOE5XX2Y1N09fcEthMXdUQkw5M215QTVRbkdCQlYxVDdWa0RuMndXaktVR0JmeGNKOW5zMzRkaWtpSW5HV3dpVkRLMGJZTUx6YjlNelBOS0pScVFubWpKYVNwWW12NzJxZmFv?oc=5" target="_blank"&gt;비급여 '입덧 치료제', 급여 추진 중 만난 '생동시험 복병'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>동국제약, '리바로젯' 제네릭 도전...후발주자 확대 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTFAyWjZXZTZsTVlkT0VIODhnSm80OFJzMnYyYkxHTVZYRVdNcDUyVGE4b2hCS2x0OEFqODlGY21IeXJlSEQwNWw0dEVWQXV1UUc1N3VXWnVYU1FMRnNnOTdKczZWaVJCaUVEYnJ1R0h3?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTFAyWjZXZTZsTVlkT0VIODhnSm80OFJzMnYyYkxHTVZYRVdNcDUyVGE4b2hCS2x0OEFqODlGY21IeXJlSEQwNWw0dEVWQXV1UUc1N3VXWnVYU1FMRnNnOTdKczZWaVJCaUVEYnJ1R0h3</guid><pubDate>Thu, 21 Aug 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFAyWjZXZTZsTVlkT0VIODhnSm80OFJzMnYyYkxHTVZYRVdNcDUyVGE4b2hCS2x0OEFqODlGY21IeXJlSEQwNWw0dEVWQXV1UUc1N3VXWnVYU1FMRnNnOTdKczZWaVJCaUVEYnJ1R0h3?oc=5" target="_blank"&gt;동국제약, '리바로젯' 제네릭 도전...후발주자 확대&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://www.dailypharm.com">데일리팜</source></item><item><title>모호했던 경구액제·시럽제 동등성자료... '이동자료'로 OK - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1OdU9FMW5CMGlscmljb0RXLXBCSFJHMTlfVFdBaWt0dFkzTERJaXdmREFVWnJFeG1KdUtrekxlalQ5b1dabHpQbTQ3TEpPWXVDd245ZEtnV0NMU1EteU9Ed0ZkN2RfNTVzbDNr?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1OdU9FMW5CMGlscmljb0RXLXBCSFJHMTlfVFdBaWt0dFkzTERJaXdmREFVWnJFeG1KdUtrekxlalQ5b1dabHpQbTQ3TEpPWXVDd245ZEtnV0NMU1EteU9Ed0ZkN2RfNTVzbDNr</guid><pubDate>Wed, 23 Mar 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1OdU9FMW5CMGlscmljb0RXLXBCSFJHMTlfVFdBaWt0dFkzTERJaXdmREFVWnJFeG1KdUtrekxlalQ5b1dabHpQbTQ3TEpPWXVDd245ZEtnV0NMU1EteU9Ed0ZkN2RfNTVzbDNr?oc=5" target="_blank"&gt;모호했던 경구액제·시럽제 동등성자료... '이동자료'로 OK&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>식약처, 제네릭 개발 많이 되는 품목 '성분별 생동시험' 공개 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTE5qdEUyaHhTOE9ESGVGSHAyRE5fWWRwel9ydktGRmczSzNDMTVJb1czdE02RmEwWjhkNF9uc0hFV2JpeElHc1VqZnV3TUZ6bUVyYXlaaGQzblFYZEY0SDBObk5XaFl3dw?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTE5qdEUyaHhTOE9ESGVGSHAyRE5fWWRwel9ydktGRmczSzNDMTVJb1czdE02RmEwWjhkNF9uc0hFV2JpeElHc1VqZnV3TUZ6bUVyYXlaaGQzblFYZEY0SDBObk5XaFl3dw</guid><pubDate>Fri, 21 Aug 2020 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE5qdEUyaHhTOE9ESGVGSHAyRE5fWWRwel9ydktGRmczSzNDMTVJb1czdE02RmEwWjhkNF9uc0hFV2JpeElHc1VqZnV3TUZ6bUVyYXlaaGQzblFYZEY0SDBObk5XaFl3dw?oc=5" target="_blank"&gt;식약처, 제네릭 개발 많이 되는 품목 '성분별 생동시험' 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://hitnews.co.kr">히트뉴스</source></item><item><title>산제, 과립제 '생동성시험 의무화'…내년엔 4개 추가 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTFBHTWFwamNFemwxWEhTYlRzSV9lTllYQks0Q3VIeE9Wb2tzUWNVMUl6cnpLRmp3WkFnXzNYZ0U0Z1ZVdFVhc2ZzbDFaa1dZdHoyYzlPZkxtRm8tY1Rjbk5TSFQ1ZGsySW9xMnc?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTFBHTWFwamNFemwxWEhTYlRzSV9lTllYQks0Q3VIeE9Wb2tzUWNVMUl6cnpLRmp3WkFnXzNYZ0U0Z1ZVdFVhc2ZzbDFaa1dZdHoyYzlPZkxtRm8tY1Rjbk5TSFQ1ZGsySW9xMnc</guid><pubDate>Tue, 23 Oct 2018 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBHTWFwamNFemwxWEhTYlRzSV9lTllYQks0Q3VIeE9Wb2tzUWNVMUl6cnpLRmp3WkFnXzNYZ0U0Z1ZVdFVhc2ZzbDFaa1dZdHoyYzlPZkxtRm8tY1Rjbk5TSFQ1ZGsySW9xMnc?oc=5" target="_blank"&gt;산제, 과립제 '생동성시험 의무화'…내년엔 4개 추가&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>"왜곡된 제네릭 시장, 생동시험 푸념은 이제 그만" - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE9NV0NKTTdZVEJuZFE2MkhlM1owUkZwUUZYYzYxMnFaalRuVzJGeTBJOWxmY2FEa1hXa3ByMDFVRFczTVk4TmpsVkNwMEF2T1N4TXZ5MDg4SDdsYjVpamJLZDNtNjVjQnRQVEE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE9NV0NKTTdZVEJuZFE2MkhlM1owUkZwUUZYYzYxMnFaalRuVzJGeTBJOWxmY2FEa1hXa3ByMDFVRFczTVk4TmpsVkNwMEF2T1N4TXZ5MDg4SDdsYjVpamJLZDNtNjVjQnRQVEE</guid><pubDate>Fri, 14 Jun 2019 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE9NV0NKTTdZVEJuZFE2MkhlM1owUkZwUUZYYzYxMnFaalRuVzJGeTBJOWxmY2FEa1hXa3ByMDFVRFczTVk4TmpsVkNwMEF2T1N4TXZ5MDg4SDdsYjVpamJLZDNtNjVjQnRQVEE?oc=5" target="_blank"&gt;"왜곡된 제네릭 시장, 생동시험 푸념은 이제 그만"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>항암제 등 품목별 생동성시험 권고사항 51건 추가 - 뉴스더보이스헬스케어</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTE9mZHhJS3M4SnAxUTYtZVVydlM1Q19VeTRCcXFIZWpscVdiTnhUQmlwMkhxRmJJMTFvNDlVTnU4eGNDT2VsSkc1Zy1fTmc0WnpHU0VaSmhKY3NFakc4MnZ1Z0h2cEZRcF9MR0I4NC0yQQ?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTE9mZHhJS3M4SnAxUTYtZVVydlM1Q19VeTRCcXFIZWpscVdiTnhUQmlwMkhxRmJJMTFvNDlVTnU4eGNDT2VsSkc1Zy1fTmc0WnpHU0VaSmhKY3NFakc4MnZ1Z0h2cEZRcF9MR0I4NC0yQQ</guid><pubDate>Thu, 20 Jun 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE9mZHhJS3M4SnAxUTYtZVVydlM1Q19VeTRCcXFIZWpscVdiTnhUQmlwMkhxRmJJMTFvNDlVTnU4eGNDT2VsSkc1Zy1fTmc0WnpHU0VaSmhKY3NFakc4MnZ1Z0h2cEZRcF9MR0I4NC0yQQ?oc=5" target="_blank"&gt;항암제 등 품목별 생동성시험 권고사항 51건 추가&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴스더보이스헬스케어&lt;/font&gt;</description><source url="https://www.newsthevoice.com">뉴스더보이스헬스케어</source></item><item><title>병원서 하는 생동시험, 임상시험과 일원화 추진 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiUEFVX3lxTE9SUUZKN0Q4QjRTeFkwV0Foa0x5STk1VWMzXzZVZHhiMkc0YlBJak1RTmFGMkEzcEVzXzVwbHhua1dLaU1pcUZoSkRUbHVVcVJU?oc=5</link><guid isPermaLink="false">CBMiUEFVX3lxTE9SUUZKN0Q4QjRTeFkwV0Foa0x5STk1VWMzXzZVZHhiMkc0YlBJak1RTmFGMkEzcEVzXzVwbHhua1dLaU1pcUZoSkRUbHVVcVJU</guid><pubDate>Fri, 28 Apr 2017 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE9SUUZKN0Q4QjRTeFkwV0Foa0x5STk1VWMzXzZVZHhiMkc0YlBJak1RTmFGMkEzcEVzXzVwbHhua1dLaU1pcUZoSkRUbHVVcVJU?oc=5" target="_blank"&gt;병원서 하는 생동시험, 임상시험과 일원화 추진&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>지난해 임상 1018건, 전년比 소폭 증가…생동시험, 22.6% 감소 - 메디파나뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1MTlR3TUotczNsQzVaakY0Y1c3bTdzZGFhQ0RWR2VrdmNPRGJnVzYzdzN5SnY1VUtQczh2TGRxNFlhQUZVRUJWOHZXUzkzb19IQlk4X2pXa0FlVVBsQzkwUVFZTmdWSE4wOUgw?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1MTlR3TUotczNsQzVaakY0Y1c3bTdzZGFhQ0RWR2VrdmNPRGJnVzYzdzN5SnY1VUtQczh2TGRxNFlhQUZVRUJWOHZXUzkzb19IQlk4X2pXa0FlVVBsQzkwUVFZTmdWSE4wOUgw</guid><pubDate>Fri, 05 Jan 2024 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1MTlR3TUotczNsQzVaakY0Y1c3bTdzZGFhQ0RWR2VrdmNPRGJnVzYzdzN5SnY1VUtQczh2TGRxNFlhQUZVRUJWOHZXUzkzb19IQlk4X2pXa0FlVVBsQzkwUVFZTmdWSE4wOUgw?oc=5" target="_blank"&gt;지난해 임상 1018건, 전년比 소폭 증가…생동시험, 22.6% 감소&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디파나뉴스&lt;/font&gt;</description><source url="https://www.medipana.com">메디파나뉴스</source></item><item><title>공동생동제한 여파로 생동시험 급증… 1년간 57% ↑ - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE40UVB5aFNBVElRQjRDb19YengzX2ViUjBYdmpDUDQ1SEpnS0NUTWczYXdOOE9FWElSWFk5T1lOTjctM0JVUTdKRUlyODk5aC02cW9zNnY3UFRWZ0JrREV6RGJRemJJMG8yZWFz?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE40UVB5aFNBVElRQjRDb19YengzX2ViUjBYdmpDUDQ1SEpnS0NUTWczYXdOOE9FWElSWFk5T1lOTjctM0JVUTdKRUlyODk5aC02cW9zNnY3UFRWZ0JrREV6RGJRemJJMG8yZWFz</guid><pubDate>Fri, 14 Jan 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE40UVB5aFNBVElRQjRDb19YengzX2ViUjBYdmpDUDQ1SEpnS0NUTWczYXdOOE9FWElSWFk5T1lOTjctM0JVUTdKRUlyODk5aC02cW9zNnY3UFRWZ0JrREV6RGJRemJJMG8yZWFz?oc=5" target="_blank"&gt;공동생동제한 여파로 생동시험 급증… 1년간 57% ↑&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>1+3 생동 제한법 시행…공포 후 신청·신고 건부터 적용 - MEDI:GATE NEWS</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTE9TcWpSX0R2UHY4MnhSOFJma1QwSXVkZ1dMYnFhLXZBTlFZLWNCYnc4eW5KX2JKRTBrekR0V0ExUG84aEwwcHlfUkhVNnI5YmhWOHlOTjF4cw?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTE9TcWpSX0R2UHY4MnhSOFJma1QwSXVkZ1dMYnFhLXZBTlFZLWNCYnc4eW5KX2JKRTBrekR0V0ExUG84aEwwcHlfUkhVNnI5YmhWOHlOTjF4cw</guid><pubDate>Tue, 20 Jul 2021 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE9TcWpSX0R2UHY4MnhSOFJma1QwSXVkZ1dMYnFhLXZBTlFZLWNCYnc4eW5KX2JKRTBrekR0V0ExUG84aEwwcHlfUkhVNnI5YmhWOHlOTjF4cw?oc=5" target="_blank"&gt;1+3 생동 제한법 시행…공포 후 신청·신고 건부터 적용&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;MEDI:GATE NEWS&lt;/font&gt;</description><source url="https://www.medigatenews.com">MEDI:GATE NEWS</source></item><item><title>식약처, 2026~2028년 주사·점안·안연고제 등 1540여 무균제제 동등 재평가 단계적 실시 - 데일리메디팜</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE9hQmRpa3o0SVdjYkdPMXBpYnBCbGF3RlZzUndpeFVUYUFJVUlUV0xEUnk4Yjd4VnBNbjBHTDk1SU5aLWJTdlBBSFpaaFhCM3k5UGplcUxZb2d3WWlOOE50NzhlRnAyYXlTeUh6ZFh3?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE9hQmRpa3o0SVdjYkdPMXBpYnBCbGF3RlZzUndpeFVUYUFJVUlUV0xEUnk4Yjd4VnBNbjBHTDk1SU5aLWJTdlBBSFpaaFhCM3k5UGplcUxZb2d3WWlOOE50NzhlRnAyYXlTeUh6ZFh3</guid><pubDate>Fri, 18 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE9hQmRpa3o0SVdjYkdPMXBpYnBCbGF3RlZzUndpeFVUYUFJVUlUV0xEUnk4Yjd4VnBNbjBHTDk1SU5aLWJTdlBBSFpaaFhCM3k5UGplcUxZb2d3WWlOOE50NzhlRnAyYXlTeUh6ZFh3?oc=5" target="_blank"&gt;식약처, 2026~2028년 주사·점안·안연고제 등 1540여 무균제제 동등 재평가 단계적 실시&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리메디팜&lt;/font&gt;</description><source url="http://m.dailymedipharm.com">데일리메디팜</source></item><item><title>"재생동 때 비동등 나도 케이스별 검토할 수 있어" - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE9nd0NlOU9qcC1mZWJ3NFIyQmJnb3dIZExxTS1OZERxc3g3Z05IbjNGdk9iVzhxckNGNmpRTWJUZHliT1lvQUZ2VjdnQ0ZzNGxieTNUZEM5SGlGZFBjbEJhdzA2dnUzb0FUbVE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE9nd0NlOU9qcC1mZWJ3NFIyQmJnb3dIZExxTS1OZERxc3g3Z05IbjNGdk9iVzhxckNGNmpRTWJUZHliT1lvQUZ2VjdnQ0ZzNGxieTNUZEM5SGlGZFBjbEJhdzA2dnUzb0FUbVE</guid><pubDate>Fri, 05 Jul 2019 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE9nd0NlOU9qcC1mZWJ3NFIyQmJnb3dIZExxTS1OZERxc3g3Z05IbjNGdk9iVzhxckNGNmpRTWJUZHliT1lvQUZ2VjdnQ0ZzNGxieTNUZEM5SGlGZFBjbEJhdzA2dnUzb0FUbVE?oc=5" target="_blank"&gt;"재생동 때 비동등 나도 케이스별 검토할 수 있어"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>내년 10월 생동대상 무균제제, 기준요건 적용 약가 재평가 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTFBVUzlpMGVIVGE2OHppbUhrTjBrZmpmUnB5eE05Yl8wZVpNZTU4REtkS09NUVd6SnJhMlk3NUJISEx5bnFtR25MdEZBTGxzcHNfa280b0otZUNHdnI4X21rNVpXcWVFUDlySUE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTFBVUzlpMGVIVGE2OHppbUhrTjBrZmpmUnB5eE05Yl8wZVpNZTU4REtkS09NUVd6SnJhMlk3NUJISEx5bnFtR25MdEZBTGxzcHNfa280b0otZUNHdnI4X21rNVpXcWVFUDlySUE</guid><pubDate>Tue, 19 Oct 2021 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBVUzlpMGVIVGE2OHppbUhrTjBrZmpmUnB5eE05Yl8wZVpNZTU4REtkS09NUVd6SnJhMlk3NUJISEx5bnFtR25MdEZBTGxzcHNfa280b0otZUNHdnI4X21rNVpXcWVFUDlySUE?oc=5" target="_blank"&gt;내년 10월 생동대상 무균제제, 기준요건 적용 약가 재평가&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="http://www.hitnews.co.kr">히트뉴스</source></item><item><title>"허가변경했어도 자체생동 이력 입증하면 기준요건 충족" - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFBGeEx3c05hcERHc3FxUnNYaUYzODJaSkFmWjkwQVNka3FVRjhLUmhyMmRQUU9USHJlNWlvNnBHVVQwVmVjbjJFVFdCemV2a0pxTmhZYlFyd0M5V1FOTGpTWldkQXZOUXRVbnBV?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFBGeEx3c05hcERHc3FxUnNYaUYzODJaSkFmWjkwQVNka3FVRjhLUmhyMmRQUU9USHJlNWlvNnBHVVQwVmVjbjJFVFdCemV2a0pxTmhZYlFyd0M5V1FOTGpTWldkQXZOUXRVbnBV</guid><pubDate>Tue, 05 Oct 2021 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBGeEx3c05hcERHc3FxUnNYaUYzODJaSkFmWjkwQVNka3FVRjhLUmhyMmRQUU9USHJlNWlvNnBHVVQwVmVjbjJFVFdCemV2a0pxTmhZYlFyd0M5V1FOTGpTWldkQXZOUXRVbnBV?oc=5" target="_blank"&gt;"허가변경했어도 자체생동 이력 입증하면 기준요건 충족"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>보령, 아브락산 제네릭 생동성시험 순항 - e-의료정보</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE9IaWpQUnUtUlVONE52NjVlQVV0MHFJMUdoSWdUSHJMSlpvUDEzQU56NmRaRHJyemdkRnBiTzdXLUVJVnVoSFEyTkQ3RnRwQW5KNjdxb3B1WGRhNDNIQ3p6TzB3SktzZ0x3bFRv0gFvQVVfeXFMTjNVeEpfanMyZTktRlgwUWJ4ancyR1djSElkYVh3N1ZYbXdzVUdiT21aV1VQS2NtME8zU05RbDEwRHc1NnU2bEI0NWlkSEc2X3lzb1NyLU85M01wZENOdUx0MWlwTEFEMU9fclV4OXlr?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE9IaWpQUnUtUlVONE52NjVlQVV0MHFJMUdoSWdUSHJMSlpvUDEzQU56NmRaRHJyemdkRnBiTzdXLUVJVnVoSFEyTkQ3RnRwQW5KNjdxb3B1WGRhNDNIQ3p6TzB3SktzZ0x3bFRv0gFvQVVfeXFMTjNVeEpfanMyZTktRlgwUWJ4ancyR1djSElkYVh3N1ZYbXdzVUdiT21aV1VQS2NtME8zU05RbDEwRHc1NnU2bEI0NWlkSEc2X3lzb1NyLU85M01wZENOdUx0MWlwTEFEMU9fclV4OXlr</guid><pubDate>Wed, 23 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9IaWpQUnUtUlVONE52NjVlQVV0MHFJMUdoSWdUSHJMSlpvUDEzQU56NmRaRHJyemdkRnBiTzdXLUVJVnVoSFEyTkQ3RnRwQW5KNjdxb3B1WGRhNDNIQ3p6TzB3SktzZ0x3bFRv0gFvQVVfeXFMTjNVeEpfanMyZTktRlgwUWJ4ancyR1djSElkYVh3N1ZYbXdzVUdiT21aV1VQS2NtME8zU05RbDEwRHc1NnU2bEI0NWlkSEc2X3lzb1NyLU85M01wZENOdUx0MWlwTEFEMU9fclV4OXlr?oc=5" target="_blank"&gt;보령, 아브락산 제네릭 생동성시험 순항&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;e-의료정보&lt;/font&gt;</description><source url="http://www.kmedinfo.co.kr">e-의료정보</source></item><item><title>일반약 필름제형 생동시험 면제될 듯…연내 고시 추진 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiUEFVX3lxTE45RktSQVVNVlJ5U1lKQjl0bU9pdVN3TmRsY0g2RGpmdkNwZDVLazNnTi0tUTIyTDVFajVDeWk1WGgtV1FrQXlZSnd1TXhyQU9V?oc=5</link><guid isPermaLink="false">CBMiUEFVX3lxTE45RktSQVVNVlJ5U1lKQjl0bU9pdVN3TmRsY0g2RGpmdkNwZDVLazNnTi0tUTIyTDVFajVDeWk1WGgtV1FrQXlZSnd1TXhyQU9V</guid><pubDate>Tue, 06 Sep 2016 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE45RktSQVVNVlJ5U1lKQjl0bU9pdVN3TmRsY0g2RGpmdkNwZDVLazNnTi0tUTIyTDVFajVDeWk1WGgtV1FrQXlZSnd1TXhyQU9V?oc=5" target="_blank"&gt;일반약 필름제형 생동시험 면제될 듯…연내 고시 추진&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>'리바로젯' 특허 8월 만료...제네릭 생동시험 활발 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiX0FVX3lxTE9odHVpeXJsNEl1UlcxUzNHRXJZUlJ1bzYyZUdSMFZZSHNQcFJZSzlTSVVLbWFJMEtQOUwyT2wxc2lwMGEzek1aTTJZTFJ4TEdnN25NYVd5dlhaaWtFLU5J?oc=5</link><guid isPermaLink="false">CBMiX0FVX3lxTE9odHVpeXJsNEl1UlcxUzNHRXJZUlJ1bzYyZUdSMFZZSHNQcFJZSzlTSVVLbWFJMEtQOUwyT2wxc2lwMGEzek1aTTJZTFJ4TEdnN25NYVd5dlhaaWtFLU5J</guid><pubDate>Fri, 14 Feb 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9odHVpeXJsNEl1UlcxUzNHRXJZUlJ1bzYyZUdSMFZZSHNQcFJZSzlTSVVLbWFJMEtQOUwyT2wxc2lwMGEzek1aTTJZTFJ4TEdnN25NYVd5dlhaaWtFLU5J?oc=5" target="_blank"&gt;'리바로젯' 특허 8월 만료...제네릭 생동시험 활발&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>'생동시험→임상시험' 상향으로 제네릭 신뢰 강화 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE9xN0RQU0hsMDVkOGpUMWQ3a1phM2tYZXIwX0lwM0VJRjlCS1BfWlhfaGpqOHNJcjlYQ1M5cC1ZNnlMamhKOW9sY2F4Q2F5RFRDSGh4YWJfdlpiR2cxTXYwVGtTbDhDOFBHb2hFTg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE9xN0RQU0hsMDVkOGpUMWQ3a1phM2tYZXIwX0lwM0VJRjlCS1BfWlhfaGpqOHNJcjlYQ1M5cC1ZNnlMamhKOW9sY2F4Q2F5RFRDSGh4YWJfdlpiR2cxTXYwVGtTbDhDOFBHb2hFTg</guid><pubDate>Tue, 17 Mar 2015 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE9xN0RQU0hsMDVkOGpUMWQ3a1phM2tYZXIwX0lwM0VJRjlCS1BfWlhfaGpqOHNJcjlYQ1M5cC1ZNnlMamhKOW9sY2F4Q2F5RFRDSGh4YWJfdlpiR2cxTXYwVGtTbDhDOFBHb2hFTg?oc=5" target="_blank"&gt;'생동시험→임상시험' 상향으로 제네릭 신뢰 강화&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>생동시험 피험자 최소 증례수 24→12명 축소 추진 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiUEFVX3lxTE5BX3JfY25HSE9lRFFPVTJGYXFhR0wxdjRuNE13cHBveVY2OGNwM0NfS05OQWs4Vnlvb0djMFpCVUlmZmpPbzFoS2hTTjZRd2Jz?oc=5</link><guid isPermaLink="false">CBMiUEFVX3lxTE5BX3JfY25HSE9lRFFPVTJGYXFhR0wxdjRuNE13cHBveVY2OGNwM0NfS05OQWs4Vnlvb0djMFpCVUlmZmpPbzFoS2hTTjZRd2Jz</guid><pubDate>Fri, 29 Aug 2014 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE5BX3JfY25HSE9lRFFPVTJGYXFhR0wxdjRuNE13cHBveVY2OGNwM0NfS05OQWs4Vnlvb0djMFpCVUlmZmpPbzFoS2hTTjZRd2Jz?oc=5" target="_blank"&gt;생동시험 피험자 최소 증례수 24→12명 축소 추진&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>품목당 최대 4억...제약, 치솟는 생동비용에 발 동동 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE9GS1hEQ1BxTXpteWM0TFhTSS1tWl9SU0JYZTBiVS1MNGZ3TGlZc0tHSktsSWxTeGhVOHh1aklITklHaG5Id2tMWV9IdGFoSlk?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE9GS1hEQ1BxTXpteWM0TFhTSS1tWl9SU0JYZTBiVS1MNGZ3TGlZc0tHSktsSWxTeGhVOHh1aklITklHaG5Id2tMWV9IdGFoSlk</guid><pubDate>Tue, 30 Apr 2019 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE9GS1hEQ1BxTXpteWM0TFhTSS1tWl9SU0JYZTBiVS1MNGZ3TGlZc0tHSktsSWxTeGhVOHh1aklITklHaG5Id2tMWV9IdGFoSlk?oc=5" target="_blank"&gt;품목당 최대 4억...제약, 치솟는 생동비용에 발 동동&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>알리코제약, 레보드로프로피진 러시아 생동성시험 뚫었다 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFAwdmZDanNmc3VIdVZmSmtpbHdOUWo0VjZIU2dMUWVsSXpZMmpVUGM4Q1dWNXlNbEQ2aG5DbWNVckY0OXdmdGVLVUdDVGxIWUZ2ZXpxSy04TlZDU1cxY25HLU4taWF6dWR3czNR?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFAwdmZDanNmc3VIdVZmSmtpbHdOUWo0VjZIU2dMUWVsSXpZMmpVUGM4Q1dWNXlNbEQ2aG5DbWNVckY0OXdmdGVLVUdDVGxIWUZ2ZXpxSy04TlZDU1cxY25HLU4taWF6dWR3czNR</guid><pubDate>Tue, 15 Apr 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFAwdmZDanNmc3VIdVZmSmtpbHdOUWo0VjZIU2dMUWVsSXpZMmpVUGM4Q1dWNXlNbEQ2aG5DbWNVckY0OXdmdGVLVUdDVGxIWUZ2ZXpxSy04TlZDU1cxY25HLU4taWF6dWR3czNR?oc=5" target="_blank"&gt;알리코제약, 레보드로프로피진 러시아 생동성시험 뚫었다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>공동생동 그룹 재평가 때 제조사 없으면 약가 불이익? - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1ndllOWUhpZE4yX2pNVmRvMVBuWU13LVpVUnpZZThoNVhXb1dBVmNHSkg2OGJTZFJHUVRBaVYtZWkwajFacFhQcFJjNlV5bl9DQ2IwOG56U1pKeWd6SmgweVpyaWxhZXJad1dv?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1ndllOWUhpZE4yX2pNVmRvMVBuWU13LVpVUnpZZThoNVhXb1dBVmNHSkg2OGJTZFJHUVRBaVYtZWkwajFacFhQcFJjNlV5bl9DQ2IwOG56U1pKeWd6SmgweVpyaWxhZXJad1dv</guid><pubDate>Thu, 09 Jul 2020 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1ndllOWUhpZE4yX2pNVmRvMVBuWU13LVpVUnpZZThoNVhXb1dBVmNHSkg2OGJTZFJHUVRBaVYtZWkwajFacFhQcFJjNlV5bl9DQ2IwOG56U1pKeWd6SmgweVpyaWxhZXJad1dv?oc=5" target="_blank"&gt;공동생동 그룹 재평가 때 제조사 없으면 약가 불이익?&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>알리코제약, 호흡기 치료제 ‘알리코프정’ 러시아 생동시험 성공 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTFB2c3d1dXpkX05ycUJ6MlFIMllaRFUyV1o5c09rbF9pWE9EbEQwbGNTQkp1a0VuLXZXTGtVSkdhT0ExUkIwVkNjQTdZc3FlSlRGZS01VTRaNGI1ZlVFdWZnRFZxWDR3aFFjdjBqY1Bn?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTFB2c3d1dXpkX05ycUJ6MlFIMllaRFUyV1o5c09rbF9pWE9EbEQwbGNTQkp1a0VuLXZXTGtVSkdhT0ExUkIwVkNjQTdZc3FlSlRGZS01VTRaNGI1ZlVFdWZnRFZxWDR3aFFjdjBqY1Bn</guid><pubDate>Tue, 15 Apr 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFB2c3d1dXpkX05ycUJ6MlFIMllaRFUyV1o5c09rbF9pWE9EbEQwbGNTQkp1a0VuLXZXTGtVSkdhT0ExUkIwVkNjQTdZc3FlSlRGZS01VTRaNGI1ZlVFdWZnRFZxWDR3aFFjdjBqY1Bn?oc=5" target="_blank"&gt;알리코제약, 호흡기 치료제 ‘알리코프정’ 러시아 생동시험 성공&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>다음달 복제약 948품목 약가 인하···생동시험 미진행 중견 제약사 타격 받을까 - 시사저널e</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTE81REpqT0ZIMmdKcWxVT3I1RHBQV3lOMURSN0NTTWZoLVJRbWFJeFdUNW5PU19BemlXN0JiMXVSOVh1QkJSSU41ZU9SUXk3NWJ4RDF6SENnMHY3OVFUMHZiaUJ5UGdBOEUyVko0Vm5QaDF6QdIBdkFVX3lxTE9QbVJjWDNVcFhuTndwTFF6dGx5TEU2YkZxUVF1em01NTdRZGdnbXp6NW9SaFFEekpMRko0cHpwdW50MEpmMmZGS2VnUGdMSDl5dU1KRF9xN0VFNEZrSnhJN0M2X0tVd0hoY1ZwZzE5c1pzSnRFcFE?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTE81REpqT0ZIMmdKcWxVT3I1RHBQV3lOMURSN0NTTWZoLVJRbWFJeFdUNW5PU19BemlXN0JiMXVSOVh1QkJSSU41ZU9SUXk3NWJ4RDF6SENnMHY3OVFUMHZiaUJ5UGdBOEUyVko0Vm5QaDF6QdIBdkFVX3lxTE9QbVJjWDNVcFhuTndwTFF6dGx5TEU2YkZxUVF1em01NTdRZGdnbXp6NW9SaFFEekpMRko0cHpwdW50MEpmMmZGS2VnUGdMSDl5dU1KRF9xN0VFNEZrSnhJN0M2X0tVd0hoY1ZwZzE5c1pzSnRFcFE</guid><pubDate>Thu, 01 Feb 2024 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTE81REpqT0ZIMmdKcWxVT3I1RHBQV3lOMURSN0NTTWZoLVJRbWFJeFdUNW5PU19BemlXN0JiMXVSOVh1QkJSSU41ZU9SUXk3NWJ4RDF6SENnMHY3OVFUMHZiaUJ5UGdBOEUyVko0Vm5QaDF6QdIBdkFVX3lxTE9QbVJjWDNVcFhuTndwTFF6dGx5TEU2YkZxUVF1em01NTdRZGdnbXp6NW9SaFFEekpMRko0cHpwdW50MEpmMmZGS2VnUGdMSDl5dU1KRF9xN0VFNEZrSnhJN0M2X0tVd0hoY1ZwZzE5c1pzSnRFcFE?oc=5" target="_blank"&gt;다음달 복제약 948품목 약가 인하···생동시험 미진행 중견 제약사 타격 받을까&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;시사저널e&lt;/font&gt;</description><source url="https://www.sisajournal-e.com">시사저널e</source></item><item><title>삼천당제약, “국내 최초 ‘케이캡’ 생동시험 동등성 확인” - 메디포뉴스</title><link>https://news.google.com/rss/articles/CBMiZEFVX3lxTE9pUTV5WUV0MmwwNHhBQ2ljUG9IVWI2a3J2ZzZ3YTNkOXRHMktwelVZdy1qcXFxMkktb1FXMmI0ank5SEl4UWdnVFhpWHphYmFkbnlGMmoxQ0hJZGtUU0VqQkNhbVA?oc=5</link><guid isPermaLink="false">CBMiZEFVX3lxTE9pUTV5WUV0MmwwNHhBQ2ljUG9IVWI2a3J2ZzZ3YTNkOXRHMktwelVZdy1qcXFxMkktb1FXMmI0ank5SEl4UWdnVFhpWHphYmFkbnlGMmoxQ0hJZGtUU0VqQkNhbVA</guid><pubDate>Fri, 11 Aug 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE9pUTV5WUV0MmwwNHhBQ2ljUG9IVWI2a3J2ZzZ3YTNkOXRHMktwelVZdy1qcXFxMkktb1FXMmI0ank5SEl4UWdnVFhpWHphYmFkbnlGMmoxQ0hJZGtUU0VqQkNhbVA?oc=5" target="_blank"&gt;삼천당제약, “국내 최초 ‘케이캡’ 생동시험 동등성 확인”&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디포뉴스&lt;/font&gt;</description><source url="https://www.medifonews.com">메디포뉴스</source></item><item><title>기등재약 재평가...제약, 약가유지용 생동시험 '딜레마' - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE5xY2lnM1JKUUJ3d3FtaUZMZ1lWOU1GZ2hXRGE1QmU0RURvS09ha1RvT1lLV1dtTnlTRTh0UXcwNkFENUVUNmI2VFJzbnpuNUFKam5ndW5OOTVxQ3RDRUxhaVdSLUxzWEh1R1dF?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE5xY2lnM1JKUUJ3d3FtaUZMZ1lWOU1GZ2hXRGE1QmU0RURvS09ha1RvT1lLV1dtTnlTRTh0UXcwNkFENUVUNmI2VFJzbnpuNUFKam5ndW5OOTVxQ3RDRUxhaVdSLUxzWEh1R1dF</guid><pubDate>Thu, 02 Jul 2020 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5xY2lnM1JKUUJ3d3FtaUZMZ1lWOU1GZ2hXRGE1QmU0RURvS09ha1RvT1lLV1dtTnlTRTh0UXcwNkFENUVUNmI2VFJzbnpuNUFKam5ndW5OOTVxQ3RDRUxhaVdSLUxzWEh1R1dF?oc=5" target="_blank"&gt;기등재약 재평가...제약, 약가유지용 생동시험 '딜레마'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>제약실무자 72% "생동시험 비동등 제네릭 회수 부당" - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE4yVTJ6OElOY1hOUDVLeU91ZzFqNkZTODU0SkpGakk0a29iT2l2bUlsbUhZRmFDaF9NS0ltcWhzVWtBVHk4TERIWVZtRXk0djg?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE4yVTJ6OElOY1hOUDVLeU91ZzFqNkZTODU0SkpGakk0a29iT2l2bUlsbUhZRmFDaF9NS0ltcWhzVWtBVHk4TERIWVZtRXk0djg</guid><pubDate>Mon, 22 Jul 2019 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE4yVTJ6OElOY1hOUDVLeU91ZzFqNkZTODU0SkpGakk0a29iT2l2bUlsbUhZRmFDaF9NS0ltcWhzVWtBVHk4TERIWVZtRXk0djg?oc=5" target="_blank"&gt;제약실무자 72% "생동시험 비동등 제네릭 회수 부당"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>식약처발 ‘의약품 동등성 재평가’...제약업계 ‘비책’은? - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFB5MVZNeHQyMl9hR0I4LURSRDNwQ2dYYTctaFp0ZUI1VkU4WDg0QS0wczlsNXRfUG5ZWnhhbFl4elR3WUZqOWF2Y2piNFlTZkJmVGJiNjJFQmtoVkJiNHVnQzU4UFVreG5Gb0R2Zw?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFB5MVZNeHQyMl9hR0I4LURSRDNwQ2dYYTctaFp0ZUI1VkU4WDg0QS0wczlsNXRfUG5ZWnhhbFl4elR3WUZqOWF2Y2piNFlTZkJmVGJiNjJFQmtoVkJiNHVnQzU4UFVreG5Gb0R2Zw</guid><pubDate>Thu, 14 Apr 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFB5MVZNeHQyMl9hR0I4LURSRDNwQ2dYYTctaFp0ZUI1VkU4WDg0QS0wczlsNXRfUG5ZWnhhbFl4elR3WUZqOWF2Y2piNFlTZkJmVGJiNjJFQmtoVkJiNHVnQzU4UFVreG5Gb0R2Zw?oc=5" target="_blank"&gt;식약처발 ‘의약품 동등성 재평가’...제약업계 ‘비책’은?&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>생동시험보고서 CTD 양식 적용 - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE5maVpKMjA4MnN5ajkzZmx0TzhheGx1VFp6WFFodjJkU0VfMzBnSThiX0U5cEYzbWQwTEhUc2VQaFR0amhqOEpoREhnQTJXb1lyVFZOQ3JBb1NJSWdkT3ZIdjJ3d2t2eFdQcm9v?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE5maVpKMjA4MnN5ajkzZmx0TzhheGx1VFp6WFFodjJkU0VfMzBnSThiX0U5cEYzbWQwTEhUc2VQaFR0amhqOEpoREhnQTJXb1lyVFZOQ3JBb1NJSWdkT3ZIdjJ3d2t2eFdQcm9v</guid><pubDate>Thu, 25 Aug 2016 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5maVpKMjA4MnN5ajkzZmx0TzhheGx1VFp6WFFodjJkU0VfMzBnSThiX0U5cEYzbWQwTEhUc2VQaFR0amhqOEpoREhnQTJXb1lyVFZOQ3JBb1NJSWdkT3ZIdjJ3d2t2eFdQcm9v?oc=5" target="_blank"&gt;생동시험보고서 CTD 양식 적용&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>"제네릭 개발 비용절감 지원"...성분별 생동시험기준 제시 - 뉴스더보이스헬스케어</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE9TZzlWeG1MalZXNmFIMnl2S0c0T1Voc2YwTDdNUmItQllCZEoyLTQ0WGVodk5ld0Naek12OFk2TVJWTDItVGRjMDg4TGdFUlRuQ3BDRTNLRTc2eE1fZkJIZ21peGRtZ29lUzgxT1hR?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE9TZzlWeG1MalZXNmFIMnl2S0c0T1Voc2YwTDdNUmItQllCZEoyLTQ0WGVodk5ld0Naek12OFk2TVJWTDItVGRjMDg4TGdFUlRuQ3BDRTNLRTc2eE1fZkJIZ21peGRtZ29lUzgxT1hR</guid><pubDate>Thu, 16 Nov 2023 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE9TZzlWeG1MalZXNmFIMnl2S0c0T1Voc2YwTDdNUmItQllCZEoyLTQ0WGVodk5ld0Naek12OFk2TVJWTDItVGRjMDg4TGdFUlRuQ3BDRTNLRTc2eE1fZkJIZ21peGRtZ29lUzgxT1hR?oc=5" target="_blank"&gt;"제네릭 개발 비용절감 지원"...성분별 생동시험기준 제시&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴스더보이스헬스케어&lt;/font&gt;</description><source url="http://www.newsthevoice.com">뉴스더보이스헬스케어</source></item><item><title>변경허가 대조약 생동 '6개월'-함량별 생동면제 강화 '2년' 뒤 시행 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE02TlMzanJmRDk1Q3VyeEJPYlVKdFg2alhlcjNzLWlvd1MwV2ZzT0V6LUVzQk1Cb01vdFdPbVBRdTdJUU5xd2F6Wk5QVWlGbllhM0pxZWplckdXRWM4WmhuZkRCZzdTQ0hKTEE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE02TlMzanJmRDk1Q3VyeEJPYlVKdFg2alhlcjNzLWlvd1MwV2ZzT0V6LUVzQk1Cb01vdFdPbVBRdTdJUU5xd2F6Wk5QVWlGbllhM0pxZWplckdXRWM4WmhuZkRCZzdTQ0hKTEE</guid><pubDate>Tue, 22 Sep 2020 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE02TlMzanJmRDk1Q3VyeEJPYlVKdFg2alhlcjNzLWlvd1MwV2ZzT0V6LUVzQk1Cb01vdFdPbVBRdTdJUU5xd2F6Wk5QVWlGbllhM0pxZWplckdXRWM4WmhuZkRCZzdTQ0hKTEE?oc=5" target="_blank"&gt;변경허가 대조약 생동 '6개월'-함량별 생동면제 강화 '2년' 뒤 시행&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="http://www.hitnews.co.kr">히트뉴스</source></item><item><title>'레코미드서방정' 재심사 만료...우판권 걸린 생동 활발 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE1Dc0FKdmkwYXFTd3c4TGktQmhxbUdBeFJJTUhCWGV2QVE4WGFhazA0dXlrY21sMy1FaVBESTlFTDZvNEk5YkFyTlhnb0xXRkE?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE1Dc0FKdmkwYXFTd3c4TGktQmhxbUdBeFJJTUhCWGV2QVE4WGFhazA0dXlrY21sMy1FaVBESTlFTDZvNEk5YkFyTlhnb0xXRkE</guid><pubDate>Thu, 22 Aug 2024 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE1Dc0FKdmkwYXFTd3c4TGktQmhxbUdBeFJJTUhCWGV2QVE4WGFhazA0dXlrY21sMy1FaVBESTlFTDZvNEk5YkFyTlhnb0xXRkE?oc=5" target="_blank"&gt;'레코미드서방정' 재심사 만료...우판권 걸린 생동 활발&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>허가 후 일반제제 제조소 변경...'생동→비교용출' 개선 - 뉴스더보이스헬스케어</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTFBkWWV6THRCOWNyVTdhYkN1TC1OUVBXbU4zd1AxcFljbkF5NnlaeWVOb2pQbTBGb1FrN1d4Y1o1U2wtQlo3cEREdEdzUmxyREQ4eV9OY1A1c3BlMFdmdENBVUtJVFNlNjFYZ0IwWUNnVQ?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTFBkWWV6THRCOWNyVTdhYkN1TC1OUVBXbU4zd1AxcFljbkF5NnlaeWVOb2pQbTBGb1FrN1d4Y1o1U2wtQlo3cEREdEdzUmxyREQ4eV9OY1A1c3BlMFdmdENBVUtJVFNlNjFYZ0IwWUNnVQ</guid><pubDate>Fri, 22 Nov 2024 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTFBkWWV6THRCOWNyVTdhYkN1TC1OUVBXbU4zd1AxcFljbkF5NnlaeWVOb2pQbTBGb1FrN1d4Y1o1U2wtQlo3cEREdEdzUmxyREQ4eV9OY1A1c3BlMFdmdENBVUtJVFNlNjFYZ0IwWUNnVQ?oc=5" target="_blank"&gt;허가 후 일반제제 제조소 변경...'생동→비교용출' 개선&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴스더보이스헬스케어&lt;/font&gt;</description><source url="https://www.newsthevoice.com">뉴스더보이스헬스케어</source></item><item><title>식약처, 무균제제 동등성 재평가 추진안 공개…"단계별 추진" - 메디파나뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFA0Q3FJcERHak9aYzJ3RUZ4MVMwemJ0R29rMHNsbG1TOWluaTNKSVFBQnhXLU5DZW05X05vLVBhN3dRLXlFamhHS3NPRy13VTFZNUE0dnM0OXRVUlp1U29aVEFDUEk4c1M2OXlZ?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFA0Q3FJcERHak9aYzJ3RUZ4MVMwemJ0R29rMHNsbG1TOWluaTNKSVFBQnhXLU5DZW05X05vLVBhN3dRLXlFamhHS3NPRy13VTFZNUE0dnM0OXRVUlp1U29aVEFDUEk4c1M2OXlZ</guid><pubDate>Wed, 16 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFA0Q3FJcERHak9aYzJ3RUZ4MVMwemJ0R29rMHNsbG1TOWluaTNKSVFBQnhXLU5DZW05X05vLVBhN3dRLXlFamhHS3NPRy13VTFZNUE0dnM0OXRVUlp1U29aVEFDUEk4c1M2OXlZ?oc=5" target="_blank"&gt;식약처, 무균제제 동등성 재평가 추진안 공개…"단계별 추진"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디파나뉴스&lt;/font&gt;</description><source url="https://www.medipana.com">메디파나뉴스</source></item><item><title>[Generic Trend]끝 보이는 '엔트레스토' 특허분쟁, 제네릭 확대 부르나 - PRESS9</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTE4ta29NakFEUzRtVFV4ZUJWX0xBZHplN3pDbXlCMFVEY19DRzlIMDF6bkNMd3ZjdGJPQVpUUjMzRXhtcTdzOGsxVkNRaVBDemlOMUxWQTVOa3FYQnl1RVh3WVpOZXdIdw?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTE4ta29NakFEUzRtVFV4ZUJWX0xBZHplN3pDbXlCMFVEY19DRzlIMDF6bkNMd3ZjdGJPQVpUUjMzRXhtcTdzOGsxVkNRaVBDemlOMUxWQTVOa3FYQnl1RVh3WVpOZXdIdw</guid><pubDate>Thu, 18 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE4ta29NakFEUzRtVFV4ZUJWX0xBZHplN3pDbXlCMFVEY19DRzlIMDF6bkNMd3ZjdGJPQVpUUjMzRXhtcTdzOGsxVkNRaVBDemlOMUxWQTVOa3FYQnl1RVh3WVpOZXdIdw?oc=5" target="_blank"&gt;[Generic Trend]끝 보이는 '엔트레스토' 특허분쟁, 제네릭 확대 부르나&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PRESS9&lt;/font&gt;</description><source url="https://www.press9.kr">PRESS9</source></item><item><title>상반기 생동승인건수 30% 증가…위탁품목 규제 영향 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE80MUJmWjVpeWpfNlJ3REFTdGctQU1QcVV4SjFfVUtvSzNlRkUxaGp0VUdVYzA0bWtKOU1YT3A1ekZIWUE3LWxfYW8wS1Y1ekE?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE80MUJmWjVpeWpfNlJ3REFTdGctQU1QcVV4SjFfVUtvSzNlRkUxaGp0VUdVYzA0bWtKOU1YT3A1ekZIWUE3LWxfYW8wS1Y1ekE</guid><pubDate>Mon, 05 Jul 2021 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE80MUJmWjVpeWpfNlJ3REFTdGctQU1QcVV4SjFfVUtvSzNlRkUxaGp0VUdVYzA0bWtKOU1YT3A1ekZIWUE3LWxfYW8wS1Y1ekE?oc=5" target="_blank"&gt;상반기 생동승인건수 30% 증가…위탁품목 규제 영향&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>제네릭 생동시험 제약사 표시·위탁업체도 품질관리 의무화 - MEDI:GATE NEWS</title><link>https://news.google.com/rss/articles/CBMiUkFVX3lxTFBma3dEbl8xUFNxSzRabllzR2xiY0hKamU0UTFST2stTXFXNHZ1cHR4bXF5a1JjVTBlYUZGZ3haTlYyQUtZNGlEX2N5VHljTlM4bUE?oc=5</link><guid isPermaLink="false">CBMiUkFVX3lxTFBma3dEbl8xUFNxSzRabllzR2xiY0hKamU0UTFST2stTXFXNHZ1cHR4bXF5a1JjVTBlYUZGZ3haTlYyQUtZNGlEX2N5VHljTlM4bUE</guid><pubDate>Mon, 01 Jun 2020 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTFBma3dEbl8xUFNxSzRabllzR2xiY0hKamU0UTFST2stTXFXNHZ1cHR4bXF5a1JjVTBlYUZGZ3haTlYyQUtZNGlEX2N5VHljTlM4bUE?oc=5" target="_blank"&gt;제네릭 생동시험 제약사 표시·위탁업체도 품질관리 의무화&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;MEDI:GATE NEWS&lt;/font&gt;</description><source url="https://medigatenews.com">MEDI:GATE NEWS</source></item><item><title>"생동 진행·계획 중인 품목은 몇 개?" 상한액 재평가 앞서 현황파악 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE52b2JscUhMWlM1YXhsMjVFUzBsMnRxZUF4WDQ2SHBIb0Yzd1F5aEZ5bU9CU0J2S3gxQlV6c3djMnlSM0RmdUV5QVRwNV8yNy1NTFgxSEJHbXZETzJqUEtyeDJCZWxLaW1fcnc?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE52b2JscUhMWlM1YXhsMjVFUzBsMnRxZUF4WDQ2SHBIb0Yzd1F5aEZ5bU9CU0J2S3gxQlV6c3djMnlSM0RmdUV5QVRwNV8yNy1NTFgxSEJHbXZETzJqUEtyeDJCZWxLaW1fcnc</guid><pubDate>Fri, 01 Jul 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE52b2JscUhMWlM1YXhsMjVFUzBsMnRxZUF4WDQ2SHBIb0Yzd1F5aEZ5bU9CU0J2S3gxQlV6c3djMnlSM0RmdUV5QVRwNV8yNy1NTFgxSEJHbXZETzJqUEtyeDJCZWxLaW1fcnc?oc=5" target="_blank"&gt;"생동 진행·계획 중인 품목은 몇 개?" 상한액 재평가 앞서 현황파악&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="http://www.hitnews.co.kr">히트뉴스</source></item><item><title>"3월부터 의약품 변경허가 땐 대조약으로 동등성시험" - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFBHb25pOVRibkl2dGJlNnJyZ09wX1FqSlB2ZzBqcThYRWdBeERiYkRwRGMzdUNsdXpQOFVzUFNCLUhfX3Zra0Fqc2E1RURNWDJHMnpBSkszRG1vTzhJOFVJOXNGU2Q1YjNuMTVj?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFBHb25pOVRibkl2dGJlNnJyZ09wX1FqSlB2ZzBqcThYRWdBeERiYkRwRGMzdUNsdXpQOFVzUFNCLUhfX3Zra0Fqc2E1RURNWDJHMnpBSkszRG1vTzhJOFVJOXNGU2Q1YjNuMTVj</guid><pubDate>Wed, 03 Feb 2021 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBHb25pOVRibkl2dGJlNnJyZ09wX1FqSlB2ZzBqcThYRWdBeERiYkRwRGMzdUNsdXpQOFVzUFNCLUhfX3Zra0Fqc2E1RURNWDJHMnpBSkszRG1vTzhJOFVJOXNGU2Q1YjNuMTVj?oc=5" target="_blank"&gt;"3월부터 의약품 변경허가 땐 대조약으로 동등성시험"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>제네릭 품질신뢰성 확보...생동평가-비교용출기준 강화 - 뉴스더보이스헬스케어</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE1oUWxPMTkzTGM3MVctM01KXzVVeV9KVmd5RDNESC14dzZVUmM3TXJ2Tld0cXhqU1I5NWpoeGVLXzRPZDFmTXd4VTNUS3VlM1RVaXh0ZExVWVY2OXJVSmMtX19qRHR5TlFNTmdSMzFR?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE1oUWxPMTkzTGM3MVctM01KXzVVeV9KVmd5RDNESC14dzZVUmM3TXJ2Tld0cXhqU1I5NWpoeGVLXzRPZDFmTXd4VTNUS3VlM1RVaXh0ZExVWVY2OXJVSmMtX19qRHR5TlFNTmdSMzFR</guid><pubDate>Wed, 30 Dec 2020 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1oUWxPMTkzTGM3MVctM01KXzVVeV9KVmd5RDNESC14dzZVUmM3TXJ2Tld0cXhqU1I5NWpoeGVLXzRPZDFmTXd4VTNUS3VlM1RVaXh0ZExVWVY2OXJVSmMtX19qRHR5TlFNTmdSMzFR?oc=5" target="_blank"&gt;제네릭 품질신뢰성 확보...생동평가-비교용출기준 강화&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴스더보이스헬스케어&lt;/font&gt;</description><source url="http://www.newsthevoice.com">뉴스더보이스헬스케어</source></item><item><title>부작용에 노출된 생동시험 피험자 - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE16VmZCS3hWaDlyUGhQT1E1d25uWTZ5Rm14RHZsdjFlQzJhdkZiaXdzR2l1ekVJckoyWVY1RW92VzcwZVI3cmY4SXdjMEh6S3NTeEV5WHRPTzRzY24wS2c1QmstUVp6bExQQkZn?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE16VmZCS3hWaDlyUGhQT1E1d25uWTZ5Rm14RHZsdjFlQzJhdkZiaXdzR2l1ekVJckoyWVY1RW92VzcwZVI3cmY4SXdjMEh6S3NTeEV5WHRPTzRzY24wS2c1QmstUVp6bExQQkZn</guid><pubDate>Fri, 07 Oct 2016 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE16VmZCS3hWaDlyUGhQT1E1d25uWTZ5Rm14RHZsdjFlQzJhdkZiaXdzR2l1ekVJckoyWVY1RW92VzcwZVI3cmY4SXdjMEh6S3NTeEV5WHRPTzRzY24wS2c1QmstUVp6bExQQkZn?oc=5" target="_blank"&gt;부작용에 노출된 생동시험 피험자&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>1+3 제한규정 시행...위탁사 신제품 운명은 수탁사 손에 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1BNDZfc3Z5dTF4YlNDRzhuRlI4U3pZMEowZTJNazNtQVFRLUFFU01Xa3owZUhVTlZwM3B2U25kWVExelBiUmJ0enpNOFpMNVhlampVMG9ZV2wwOVVkc0t4cmRFQ0hfMkJDRE1z?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1BNDZfc3Z5dTF4YlNDRzhuRlI4U3pZMEowZTJNazNtQVFRLUFFU01Xa3owZUhVTlZwM3B2U25kWVExelBiUmJ0enpNOFpMNVhlampVMG9ZV2wwOVVkc0t4cmRFQ0hfMkJDRE1z</guid><pubDate>Wed, 21 Jul 2021 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1BNDZfc3Z5dTF4YlNDRzhuRlI4U3pZMEowZTJNazNtQVFRLUFFU01Xa3owZUhVTlZwM3B2U25kWVExelBiUmJ0enpNOFpMNVhlampVMG9ZV2wwOVVkc0t4cmRFQ0hfMkJDRE1z?oc=5" target="_blank"&gt;1+3 제한규정 시행...위탁사 신제품 운명은 수탁사 손에&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>마더스제약, 펠루비 제네릭 개발…생동시험 첫 개시 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE5BTW02ZDVnaWcxM21SX0NyTnRLalFCZng2aGpiTURabHdDaDFhSkU2Rm5ZbVZtTmE3RHBGc2xyVnloQ3FRanN3Z3VBMHhBOHc?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE5BTW02ZDVnaWcxM21SX0NyTnRLalFCZng2aGpiTURabHdDaDFhSkU2Rm5ZbVZtTmE3RHBGc2xyVnloQ3FRanN3Z3VBMHhBOHc</guid><pubDate>Wed, 04 Mar 2020 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE5BTW02ZDVnaWcxM21SX0NyTnRLalFCZng2aGpiTURabHdDaDFhSkU2Rm5ZbVZtTmE3RHBGc2xyVnloQ3FRanN3Z3VBMHhBOHc?oc=5" target="_blank"&gt;마더스제약, 펠루비 제네릭 개발…생동시험 첫 개시&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>1+3 공동생동 규제 가시화…수혜 기업에 ‘쏠리는 눈’ - 메디코파마</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTE5Cekw5dkVQX2tSTGxUSW4xVU1lOWl4enNrMkZBTUZ5cTNmMm8tdHJQWGowSG9rSTAxVHo0Qy1TZzlQaTlyeWhaOVI3QVJNZkNkcklkYS1VaWVJSi1vT1otZEZqMXlYRUItOXZPaVBwTXlyUQ?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTE5Cekw5dkVQX2tSTGxUSW4xVU1lOWl4enNrMkZBTUZ5cTNmMm8tdHJQWGowSG9rSTAxVHo0Qy1TZzlQaTlyeWhaOVI3QVJNZkNkcklkYS1VaWVJSi1vT1otZEZqMXlYRUItOXZPaVBwTXlyUQ</guid><pubDate>Mon, 03 May 2021 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTE5Cekw5dkVQX2tSTGxUSW4xVU1lOWl4enNrMkZBTUZ5cTNmMm8tdHJQWGowSG9rSTAxVHo0Qy1TZzlQaTlyeWhaOVI3QVJNZkNkcklkYS1VaWVJSi1vT1otZEZqMXlYRUItOXZPaVBwTXlyUQ?oc=5" target="_blank"&gt;1+3 공동생동 규제 가시화…수혜 기업에 ‘쏠리는 눈’&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디코파마&lt;/font&gt;</description><source url="https://www.medicopharma.co.kr">메디코파마</source></item><item><title>"생동결과 자료 몰리면 식약처 검토 늦어져...올해 제출부탁" - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTFBINVpRSDBVZS1tdUJhTVZlT0xCbVpmeWZRRXN6em1naUVkVGVnelBqWkZaaVcxdEw5Zlk0ZE9BTU41bHhQQWJRRXRhRHJUUWNXX0p0c0xkWHhYMmM1OWd1LWpfeHRFdnpHZXc?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTFBINVpRSDBVZS1tdUJhTVZlT0xCbVpmeWZRRXN6em1naUVkVGVnelBqWkZaaVcxdEw5Zlk0ZE9BTU41bHhQQWJRRXRhRHJUUWNXX0p0c0xkWHhYMmM1OWd1LWpfeHRFdnpHZXc</guid><pubDate>Wed, 22 Jun 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBINVpRSDBVZS1tdUJhTVZlT0xCbVpmeWZRRXN6em1naUVkVGVnelBqWkZaaVcxdEw5Zlk0ZE9BTU41bHhQQWJRRXRhRHJUUWNXX0p0c0xkWHhYMmM1OWd1LWpfeHRFdnpHZXc?oc=5" target="_blank"&gt;"생동결과 자료 몰리면 식약처 검토 늦어져...올해 제출부탁"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="http://www.hitnews.co.kr">히트뉴스</source></item><item><title>제네릭 약가 차등제 연계된 '생동성시험' 다시보기 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTE56X1NYTzVwUTN4QVJ1NHY5c0pWM2gzUXZpejZfYk5uZWxFQm0tM1RBb3hEMmszb0dydEVzRXpDbWExdnA4SDBFOXh1SzVRUmgwaU43ZnpUMUdIbFZpNVlSYUZlWm93dw?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTE56X1NYTzVwUTN4QVJ1NHY5c0pWM2gzUXZpejZfYk5uZWxFQm0tM1RBb3hEMmszb0dydEVzRXpDbWExdnA4SDBFOXh1SzVRUmgwaU43ZnpUMUdIbFZpNVlSYUZlWm93dw</guid><pubDate>Sat, 30 Mar 2019 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE56X1NYTzVwUTN4QVJ1NHY5c0pWM2gzUXZpejZfYk5uZWxFQm0tM1RBb3hEMmszb0dydEVzRXpDbWExdnA4SDBFOXh1SzVRUmgwaU43ZnpUMUdIbFZpNVlSYUZlWm93dw?oc=5" target="_blank"&gt;제네릭 약가 차등제 연계된 '생동성시험' 다시보기&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://www.dailypharm.com">데일리팜</source></item><item><title>'더 이상 예외는 없다'…생동성 시험 판정기준 상향 '예고' - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFBLQnpTeDJ6QjdZR3JGdnpKdFdSM0FUWXpGdmI3VGx0RUZDdGVaVlMyT3M1YXBDd2hjTVhvcjZYS2hMSFA4QURETEV1M3VjYkF6ZjlfS2VsN1R5OERzZ1h1alFNX25FX3RvUGVGSg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFBLQnpTeDJ6QjdZR3JGdnpKdFdSM0FUWXpGdmI3VGx0RUZDdGVaVlMyT3M1YXBDd2hjTVhvcjZYS2hMSFA4QURETEV1M3VjYkF6ZjlfS2VsN1R5OERzZ1h1alFNX25FX3RvUGVGSg</guid><pubDate>Fri, 29 Nov 2019 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBLQnpTeDJ6QjdZR3JGdnpKdFdSM0FUWXpGdmI3VGx0RUZDdGVaVlMyT3M1YXBDd2hjTVhvcjZYS2hMSFA4QURETEV1M3VjYkF6ZjlfS2VsN1R5OERzZ1h1alFNX25FX3RvUGVGSg?oc=5" target="_blank"&gt;'더 이상 예외는 없다'…생동성 시험 판정기준 상향 '예고'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>코러스 동등성분과 키워드는 ①유사성인자 ②BCS ③재평가 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFA0YTJhd3Jwc2NvdVBKVzdkSG5uYmlMVVZvYUliMW85TEEzbVQyekxkdnZyenZ4NmZvWXFqNU1qcG5hNEFRdTE4aXFabXA3Qm1OTG1iUFpTNjhwNWZ4QW42clhBWDEyN3R6Q180?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFA0YTJhd3Jwc2NvdVBKVzdkSG5uYmlMVVZvYUliMW85TEEzbVQyekxkdnZyenZ4NmZvWXFqNU1qcG5hNEFRdTE4aXFabXA3Qm1OTG1iUFpTNjhwNWZ4QW42clhBWDEyN3R6Q180</guid><pubDate>Thu, 30 Mar 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFA0YTJhd3Jwc2NvdVBKVzdkSG5uYmlMVVZvYUliMW85TEEzbVQyekxkdnZyenZ4NmZvWXFqNU1qcG5hNEFRdTE4aXFabXA3Qm1OTG1iUFpTNjhwNWZ4QW42clhBWDEyN3R6Q180?oc=5" target="_blank"&gt;코러스 동등성분과 키워드는 ①유사성인자 ②BCS ③재평가&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>식약처 ‘임상-생동 통합’ 무엇이 달라지나 - 의약뉴스</title><link>https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9pWTB0MmVYV2t1aXRldEQ1ZVduXzNxc25OV3ZrUzRrWW9YSzY0UU5GT0w4S1ZIVG8zZ3JQelo4dVY2WmtId1JjSmEteERCZ1JjdWJtNXo3V2VBbmFjZG5UeHcwalY5UWM?oc=5</link><guid isPermaLink="false">CBMiZ0FVX3lxTE9pWTB0MmVYV2t1aXRldEQ1ZVduXzNxc25OV3ZrUzRrWW9YSzY0UU5GT0w4S1ZIVG8zZ3JQelo4dVY2WmtId1JjSmEteERCZ1JjdWJtNXo3V2VBbmFjZG5UeHcwalY5UWM</guid><pubDate>Tue, 28 Nov 2017 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9pWTB0MmVYV2t1aXRldEQ1ZVduXzNxc25OV3ZrUzRrWW9YSzY0UU5GT0w4S1ZIVG8zZ3JQelo4dVY2WmtId1JjSmEteERCZ1JjdWJtNXo3V2VBbmFjZG5UeHcwalY5UWM?oc=5" target="_blank"&gt;식약처 ‘임상-생동 통합’ 무엇이 달라지나&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의약뉴스&lt;/font&gt;</description><source url="http://www.newsmp.com">의약뉴스</source></item></channel></rss>